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Chronic illnesses, including Inflammatory Bowel Disease (IBD), present 
individuals with an array of physical and psychological challenges. To successfully 
address psychological distress or foster resilience in those living with chronic illness, it 
is important to understand the factors that underpin such outcomes. This research aimed 
to: 1) understand the association between illness uncertainty and psychological distress 
in those with chronic illness, and; 2) develop a theoretical and empirically informed 
understanding of resilience in those with IBD. 
A systematic review and narrative synthesis examined the association between 
illness uncertainty and psychological distress in people with chronic illnesses. A 
systematic search of three electronic databases yielded 23 studies. Specific 
inclusion/exclusion criteria were applied. All studies used self-report measures and all 
but one study, employed a cross-sectional design. Overall, low to moderate levels of 
illness uncertainty were present across the study samples. The synthesis illuminated the 
association between illness uncertainty and psychological distress (measured as 
depression, anxiety, negative mood states and trauma symptoms). This association 
remained regardless of individual or contextual factors, time across the illness trajectory; 
and when confounding variables were controlled for. Appraisals of illness uncertainty 
need further exploration, but studies have begun examining control-beliefs and 
intolerance of uncertainty. Limitations of the studies are discussed and further 
recommendations for future research are presented.  
Recent research in the IBD field has begun exploring beliefs about illness and 
disease-related variables and their association with resilience and other outcomes. This 
exploratory research employed a cross-sectional, sequential mixed methods design. 
Therefore, findings from a scoping literature search and qualitative phase, eliciting 
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personal, voiced resilience experiences via interviews, informed a quantitative 
examination of factors and their association with resilience, using an online survey. Those 
over 18 years and with self-reported IBD diagnoses participated in the study. Five people 
participated in interviews. Potential factors comprising an important part of resilience 
were identified from the scoping review. The thematic analysis of the interview data 
supported these and the construct of grit additionally emerged (perseverance towards 
long-term goals). Next, eighty-five participants completed an online survey to test 
measures of social support, coping-efficacy and illness-acceptance (illness cognitions and 
coping resources); control-beliefs and intolerance of uncertainty (beliefs related to 
controllability); grit; time since diagnosis, disease activity and disease subtype (disease 
related variables); and their association with resilience (dependent variable).  
Correlational analyses and a hierarchical regression analysis were conducted. 
Disease activity, illness-acceptance, social support, coping efficacy, control-beliefs and 
intolerance of uncertainty contributed 67.1% of the variance in resilience. Non-significant 
associations were found between grit, time since diagnosis and resilience. Daily 
persistence and endurance may be more characteristic of resilience in those with IBD. 
Limitations of the study are acknowledged, and recommendations for future clinical 
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Section 1: Literature review 
 
How does illness uncertainty relate to psychological distress in chronic illness 







Illness uncertainty (IU) arises when illness related events have indeterminable meaning 
and adequate cognitive schema cannot be formed to interpret the meaning of such 
phenomena. IU has been associated with negative outcomes. This review aimed to 
synthesise papers examining the IU/psychological distress association in chronic illness 
populations; to understand it in relation to care-context, chronic illness type or form of 
psychological distress. This intended to draw conclusions to inform future research and 
clinical practice. 
Method 
Three electronic databases were systematically searched for studies that met pre-defined 
inclusion criteria, including use of an IU measure based on Mishel’s conceptualisation. 
The ‘Observational Cohort and Cross-sectional Studies’ tool was employed to assist 
quality appraisal and papers were narratively synthesised. 
Results  
The search yielded 23 papers (total participants, N=3126). Twenty-one studies 
demonstrated positive and significant associations between IU and psychological 
distress irrespective of gender, care-context, time across the illness trajectory, chronic 
illness type or form of psychological distress. The ambiguity element of Mishel’s IU 
conceptualisation yielded more significant associations and larger effect sizes than other 
facets of IU (complexity, inconsistency, and unpredictability). There was a tendency for 
greater IU to associate with subjective rather than objective illness severity. Intolerance 
of uncertainty and control beliefs as appraisal processes associated with IU and 




IU associates with psychological distress regardless of individual or contextual 
differences. It is inferred from existing theoretical frameworks that appraisals mediate 
the association, but research is needed to explore causal pathways and specific appraisal 
processes linked with IU in chronic illness populations. 
.Practitioner points 
• The presence of IU is ubiquitous in chronic illness populations and 
should be routinely assessed and normalised. 
• Healthcare professionals should assess and target the different facets of 
IU using Mishel’s original measure and varying manifestations of 
psychological distress in those with chronic illnesses. 
• Healthcare professionals should follow current National Institute for 
Health and Care Excellence guidance on the psychological treatment of 
emotional disorders (cognitive behavioural therapy) but assess for 
appraisal processes associated with IU. 
Limitations 
• The cross-sectional designs employed meant that causal associations 
could not be determined. 
• Findings were not generalisable to all chronic illness populations and 
65.2% of studies were conducted in the United States of America, 
limiting the cross-cultural validity of the findings. 
• Few studies conducted power analyses; thus, it was difficult to determine 
if studies were sufficiently powered to avoid type 1 or II errors. 
Therefore, findings should be interpreted with caution.   
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Illness uncertainty: An overview of definitions and models 
Uncertainty has been defined as a complex cognitive stressor and perceptual 
state or attitude of doubt or not knowing that changes over time (Mast, 1995; Wiener & 
Dodd, 1993). It is an ubiquitous human experience but is particularly poignant for those 
living with chronic illness (CI, Hilton, 1994; Mishel, 1990), because they present 
individuals with prolonged physical and psychological challenges. One potential 
challenge is IU which occurs when “adequate cognitive schema cannot be formed with 
which to interpret the meaning of illness-related events” (Mishel, 1997, p.225). 
Insufficient coping to buffer negative emotional responses can lead to protracted or 
unresolved psychological distress which can precede the need for clinical services. It is 
thus the focus of this review to develop an understanding of the association between IU 
and psychological distress in those living with CI. 
IU has been conceptualised in many ways. One such conceptualisation suggests 
its synonymity to emotions evoked by illness-related events that can be positive or 
threatening (Hilton, 1994). Conversely, in the uncertainty in illness theory (UIT, 
Mishel, 1981), IU is proposed to be a “neutral cognitive state” (Mishel, 1997, p.58) 
distinct from its emotional outcomes (McCormick, 2002). The UIT has become the 
most established and researched framework and differing versions of measures based 
upon Mishel’s conceptualisation have been cited as the most widely used (Wright et al., 
2009). The original Mishel Uncertainty in Illness Scale-Acute (MUIS-A, Mishel, 1981) 
captures four facets of IU. These include ambiguity; meaning information (symptoms or 
causes) can be vague and interpretable in several ways: complexity; uncertainty about 
treatment and the medical system; inconsistency; the symptom pattern presenting as 
variable and in discord with the disease process: and unpredictability, the inability to 




 Contentions underpin the presumed causes and influencing factors of IU. Hilton 
(1992) suggested that lack of information underlies uncertainty, whereas Mishel (1997) 
placed emphasis on indeterminable meaning which comprises a multitude of factors, 
acknowledging IU is a multifaceted concept (McCormick, 2002). Four major 
components of IU are proposed, including: antecedents generating uncertainty; the 
appraisal of uncertainty, coping and affect control strategies; and adaptation to the 
illness. Poor cognitive abilities, low education levels and limited social support have 
also been associated with high levels of IU in CI populations (Liao et al., 2008; Lien et 
al., 2009; Mast, 1998). Thus, contextual, and individual factors influence IU. 
Mishel’s (1981) uncertainty in illness concept and theoretical underpinnings. 
The UIT drew upon Lazarus and Folkman’s (1984) stress and coping model, 
which illuminated the importance of the appraisal generated from uncertainty. Appraisal 
processes and the ways in which individuals cope with IU are variable (Alschuler & 
Beier, 2015). IU is not necessarily aversive until negatively appraised. Negative 
appraisals include thoughts related to danger (a threat to well-being) or hopelessness 
(Mishel, 1990). Mishel (1981, 1984) postulates that adaptive, promising outcomes are 
borne out of positive appraisals, such as that illness experiences provide opportunity 
(Mishel, 1981; Mishel, 1984). Conversely negative appraisals lead to the adoption of 
maladaptive coping strategies to manage affect, leading to outcomes of psychological 
distress (Mishel, 1988).  
The UIT was originally applied to acute illness experiences (Mishel, 1988), but 
reconceptualised to address the phenomenology of continuous uncertainty in those with 
CI (Mishel, 1990). Within the theory it is suggested that living with IU chronically, 
destabilises pre-existing cognitive models of life as predictable and controllable, and 
thus IU becomes accepted as part of reality (Alligood, 2014). There is henceforth a shift 
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of perspective from danger to opportunity which may lead to positive psychological 
changes (Mishel, 1990). However, this has been critiqued because how meaning is 
assigned to IU and transformed to opportunity appraisals is an idiosyncratic process that 
lacks empirical backing (Alligood, 2014). Furthermore, Bailey and Neilson (1993) 
found no association between illness duration (mean duration was 17 years), IU, and its 
appraisal in those with rheumatoid arthritis.  
The UIT shares the conceptual underpinnings of Beck’s (1967) cognitive theory 
of emotional disorders arguing that appraisals (about self, world, and future) are 
pertinent to the development of psychopathology; thoughts/appraisals impact on 
emotions which influence coping behaviours. Hence, appraisals of uncertainty in the 
context of a CI, may lead to undesirable outcomes. Intolerance of uncertainty which is 
defined as negative reactions to uncertainty on emotional, cognitive, and behavioural 
levels (Buhr & Dugas, 2009) has been extensively researched. Intolerance of 
uncertainty has been conceptually and empirically linked with generalised anxiety 
disorder (Dugas et al., 1998; Dugas & Robichaud, 2007; Freeston et al., 1994) and other 
emotional disorders (Gentes & Ruscio, 2011).  
Empirical support for Mishel’s (1981) uncertainty in illness theory. 
It has been argued that much of the research supporting the UIT dedicated its 
focus to the association between IU and psychosocial outcomes rather than the 
mediating roles of appraisals (McCormick, 2004). Hence, only extant research scaffolds 
the IU, appraisal link. For example, higher uncertainty associates with danger appraisal 
(Bailey & Neilsen 1993). The extensive research on IU and outcomes has been 
conducted with varying populations, including paediatrics (Fortier et al, 2013) and 
chronic pain (Wright et al., 2009).  A large tranche of empirical research on acute and 
CI populations, links IU with reduced Quality of Life (QOL, Chen et al., 2018; Fedele 
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et al., 2009; Padilla, 1992), lower adjustment (Christman, 1990; Mishel & Baden, 
1987), negative mood states (Christman et al., 1988; Lin et al., 2013; Lutze & 
Archenholtz, 2007; Wineman, 1990; Wineman et al., 2003), poorer emotional well-
being and depressive symptoms  (Bailey et al., 2009; Bang et al., 2013; Hoth et al., 
2013; Mishel, 1981; Wang et al., 2014). Accordingly, higher levels of certainty have 
correlated with better QOL and psychosocial adaptation (McNulty et al., 2004; Niv et 
al., 2017).    
Some internal resources have been found to mediate between IU and outcomes, 
including optimism (Christman, 1990; Mishel et al., 1984; Mishel & Sorenson, 1991), 
hope (Christman, 1990; Hilton, 1994), mastery (Mishel et al., 1991) and learned 
resourcefulness (Rosenbaum, 1983). Furthermore ‘grit’, or persistence despite challenge 
(Duckworth et al., 2007), has been linked with lower IU and thus decreased distress 
(Sharkey et al., 2017).  
Chronic Illnesses 
The Department of Health (DOH, 2017) defines CIs as “complex… multiple 
causes… generally long-term and persistent, and often lead to a gradual deterioration of 
health and loss of independence. While not usually immediately life threatening, 
chronic conditions are the most common and leading cause of premature mortality” 
(p.6).  Moreover, they are not passed from person and person and are of long duration 
with generally slow progression (World Health Organisation, WHO, 2016). CIs range 
from medication-controlled asthma or diabetes; to neurodegenerative diseases such as 
Multiple Sclerosis or Parkinson’s disease which present individuals with significant 
experiences of pain and the threat of unpredictable but gradual decline. Though distinct 
CI’s vary in their clinical profile, they share common characteristics, including 
uncertain aetiology, symptom ambiguity, uncontrollable or fluctuating trajectories and 
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uncertain prognosis. Uncertainty can be exacerbated by the ever-present potential for 
decline in health functionality (Mishel, 1990).  
Psychological distress 
Psychological distress is frequently referenced in health-care literature, but as a 
distinct concept, it has not been clearly defined and articulated (Ridder, 2004). It is 
conceptually linked with stress and distress, considered the “unique discomforting, 
emotional state experienced by an individual in response to a specific stressor” (Ridder, 
2004, p.539). It has also been characterised by symptoms of depression and anxiety 
(Drapeau et al., 2012), which have been named as leading causes of morbidity and 
disability (Prince et al., 2011). Those with CI’s have higher rates of depression and 
anxiety than physically healthy controls and approximately 20% of those with a CI have 
depression (NICE, 2010). Existing systematic reviews have measured psychological 
distress multidimensionally (Gong et al., 2016; Kuswanto et al., 2018), capturing 
depression, anxiety, trauma symptomatology, mood states and perceived stress 
symptoms. Research included in this review captures these wider measures of 
psychological distress.  
The current review 
Existing reviews have focused on IU and outcomes in specific populations; 
including caregiver and paediatric uncertainty in relation to young people with CI 
(Szulxzewski et al., 2017) and chronic pain (Wright et al., 2009). Szulxzewski et al. 
(2017) conducted a meta-analysis and found associations between child and caregiver 
uncertainty and outcomes of depression, anxiety, and psychological distress in young 
people, with medium effect sizes. Wright et al’s. (2009) concept review was not 
systematically conducted which may have introduced several biases. However, they 
found IU to be associated with maladaptive coping and higher psychological distress.  A 
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plethora of individual quantitative studies that have examined the IU and psychological 
distress association in adult CI populations exist, however no study has synthesised 
findings. 
This timely review carries clinical and empirical importance. A synthesis offers 
a nuanced understanding of the association between IU and psychological distress 
according to CI-type and care-context. Furthermore, the NICE (2010, guideline 91) 
recommended cognitive behaviour therapy treatment of depression is based on a 
standardised manual, rather than being tailored to addressing the psychological 
processes associated with CI. A nuanced understanding of IU, psychological distress 
and associated variables could facilitate an understanding of what psychological 
processes health care professionals (HCP’s) might assess and target in CI populations; 
and highlight those more vulnerable to moving towards a trajectory of negative 
outcomes. This could be valuable for those working in primary care, hospital settings, 
health, and psychology departments and psychological therapists.  
The review question was developed using the PICO (population, intervention, 
comparator, and outcome) framework (Moher et al., 2015), culminating in the final 
review question: How does illness uncertainty relate to psychological distress in chronic 
illness populations? 
This review had five aims: 1) Examine the commonality of IU and the general 
trend across all studies examining the association between IU and psychological distress 
across CI populations; 2) consider the association between IU and psychological 
distress across differing care-contexts; 3) examine the association between IU and 
varying types of psychological distress; 4) elucidate how this association might 
differentiate across CI types; 5) identify other variables that have been examined in 






The review protocol was registered with the international Prospective Register 
of Systematic Reviews (PROSPERO, Registration number: CRD42020166475). This 
review followed the ‘Preferred Reporting Items for Systematic Reviews and Meta-
Analyses’ (PRISMA; Moher et al., 2009) guidance. Systematic narrative reviews 
involve methodically selecting, summarising and critically appraising available research 
(Moher et al., 2009). In line with narrative synthesis guidance (Popay et al., 2006) a 
preliminary synthesis of study findings was conducted, and patterns elicited. Next the 
studies were summarised, and consideration given to the direction and magnitudes of 
effects. Subsequently, exploration of the similarities, differences and relationships 
within the data was undertaken, accounting for quality appraisal (Lisy & Poritt, 2016).  
Search strategy  
Three electronic databases, Scopus, Psycinfo and MEDLINE (all titles, 
abstracts, keywords) were searched on 20th February 2020, from database inception, 
with no date restrictions. This enabled the search to capture and synthesise all available 
research. Only English language papers were included. Search concepts were developed 
using PICO (Moher et al., 2015); no search concepts were included regarding 
comparator or study design. Search terms were developed (See Appendix A) from 
preliminary scans of the literature, thesaurus searching the key constructs and informed 
by previous reviews studying CI populations (Amo-Setien et al., 2019; Cal et al., 2015; 
Snippen et al., 2019; Szulczewski et al., 2017). Search-terms included “chronic* ill*”, 
illness uncertainty”, “Mishel* illness uncertainty scale” and “psychological distress*”. 
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Boolean operators were utilised to connect terms and combine specificity and sensitivity 
to yield eligible studies (meeting the inclusion/exclusion criteria).   
A PRISMA diagram is presented in figure 1 and provides a summary of the 
search and selection process (Moher et al., 2009). Where full text articles were not 
accessible, main authors were contacted which enabled all papers to be successfully 
obtained. To enable a comprehensive search, reference lists of identified papers elicited 
by the above systematic search were hand searched; one additional paper was identified 
and included in the final review using this method (Detprapon et al., 2004). A forward 
and backward citation search was conducted on all included papers; two papers were 
identified which were unavailable in English language and thus excluded. Screening 
resulted in duplicates being removed initially and eligibility subsequently being 
ascertained by title, and then abstract inspection. If it was unclear if papers met 
inclusion/exclusion criteria, full articles were inspected. 
Inclusion/exclusion criteria 
Papers were included according to inclusion and exclusion criteria (see 
Appendix B). Papers needed to include a CI or form of psychological distress cohering 
with the definitions discussed in this review (DOH, 2017; Ridder, 2004; WHO, 2016). 
They were also required to employ an IU measure based on Mishel’s conceptualisation 
so that there was some homogeneity pertaining to what constituted IU in terms of 
definition and measurement (e.g. Hagen et al., 2015; Mishel 1981; Mishel, 1986). 
Where it was unclear if a paper met inclusion, this was reconciled through 
discussions with research supervisors, with consideration of the papers content and 
relevance to the review question. Illustratively, two papers were included studying 
survivors of childhood cancer (Lee, 2006; Santacroce & Lee, 2006). The key rationale 
for inclusion was that recurrent disease has been found to be 4.4%, 5.6%, and 6.2% at 
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10, 15, and 20 years post-paediatric cancer survival respectively (Wasilewski-Masker et 
al., 2009); survivor death rates have been found to exceed age-matched controls, with 
death from subsequent cancer being the most frequent cause (Mertens et al., 2015). 
Exclusion-criteria included IU measurement pre-post major surgery or drug trial 
participation as this was deemed to capture something phenomenologically distinct. 
However, papers were included for those with a CI undergoing protracted treatments 
such as haemodialysis (e.g. B. Kim & J. Kim, 2019) or chemotherapy (e.g. Kurita et al., 
2013). 
Measures of illness uncertainty using Mishel’s conceptualisation of IU 
Mishel (1983) advocated the development of measures for specific illness and 
diagnostic groups. Hence several versions have been developed since the original 33-
item MUIS-A (Mishel, 1981). The measures employed by papers in this review are 
described. All measures have demonstrated robust psychometric properties (See 
Appendix C for psychometric properties). 
The MUIS-A measures all facets of IU thus containing subscales of ambiguity, 
complexity, inconsistency, and unpredictability. It includes questions related to acute 
illness and hospitalisation. A 28-item two factor MUIS version (Mishel, 1997) including 
subscales ambiguity (16 items) and complexity (12 items) was subsequently developed. 
The 23-item Mishel Uncertainty in Illness Scale-Community (MUIS-C, Mishel, 1991) 
was adapted from the MUIS-A and thus contains similar items. However, those items 
related to hospitalisation of acutely ill patients were removed; it was designed for 
community-dwelling individuals, unlikely to be undergoing medical interventions and 
differed in its use of a unidimensional scale. B. Kim & J. Kim (2019) used the Korean 
translation (Jung et al., 2005). The 5-item Mishel Uncertainty in Illness Scale-Short 
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Form (MUIS-SF, Hagen et al., 2015) captures ambiguity about and controllability of the 
illness; and complexity of treatment/system of care as a unitary construct.  
Data extraction 
The following data were extracted and tabulated (see Table 1): author(s), 
publication year, country of publication, sample characteristics (CI, sample size, 
percentage female, age ranges, mean age), recruitment setting, study design, sampling 
method, measures of IU and psychological distress adopted by each study, and finally the 
correlation coefficients (r) between the IU and psychological distress measure; which 
indicated the effect size (Ellis, 2010). Effects sizes were interpreted according to Cohen’s 
(1988) guidelines; r=0.10 to 0.29 (small), r=0.30 to 0.49 (medium) and r=0.50 to 1.00 
(large). Where r-square value was used Cohen’s (1992) guidance was followed; <0.12 
(low association with outcome), 0.13 to 0.25 (medium); and >0.26 (large).  
In papers where the association between IU and psychological distress was not 
the predominant focus, bivariate correlational findings (with correlation coefficients) 
were extrapolated. Where possible, partial correlations were also reported.  
Quality appraisal  
The quality of papers included in a review can impact on the validity of its 
results (Centre for Reviews & Dissemination, 2008). Assessment of study quality was 
conducted using the 14-item Observational Cohort and Cross-sectional Studies tool 
(National Institutes of Health, 2014, see Appendix D for items). A checklist is provided 
allowing for analysis of transparency, consistency, and validity; enabling papers to be 
rated as ‘poor’, ‘fair’, or ‘good’. Items are rated as ‘yes’, ‘no’, ‘cannot-determine’, ‘not 
reported’ or ‘non-applicable’. No guidelines offer categorisation of numerical ratings 
and some items were not applicable to the study design. Thus, for the purpose of this 
review, non-applicable items were excluded from the scoring and a percentage rating 
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was calculated to facilitate comparisons of study quality (total score/applicable items x 
100). The author applied the principles that <50%= poor;  50%-70%=fair and 
>70%=good. Table 1 presents percentage and quality ratings.  
An independent final-year clinical psychology doctoral trainee with experience 
of quality appraisal and who was blind to the main author’s ratings, rated 5 randomly 
selected papers. This intended to confirm inter-rater reliability of the quality assessment.  
Any disparities in ratings were discussed until a consensus was reached (the final agreed 
ratings are presented in Table 1). Overall, the quality of the studies included in this 
review was deemed fair (N=15) or good (N=8) (see Appendix E). No studies received a 
‘poor’ rating. Discussion of individual aspects of study quality are additionally 
embedded within the review findings. 
Results 
In total the systematic search culminated in the inclusion of 23 studies (see figure 
1). Table 1 summarises the key study characteristics and extracted data from the reviewed 
studies.   
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Figure 2   
































Records identified through database searching: 
n=3851 
 




Titles screened  
n=3708 
                 Papers excluded: n=115 
a) Before/after major treatment=30 
b) Age of participants=14 
c) Excluded on the basis of outcomes=37 
d) Proxy measures of IU used=10 
e) Participant sample diagnoses of 
exclusion/acute conditions=15 
f) Non-peer reviewed articles=3 
g) Qualitative methodology= 4 
h) Did not use a version of Mishel’s IU 
scale=2 
 































Papers excluded: n=19 
a) Before/after major treatment=4 
b) No direct statistical examination of IU and 
psychological /distress=4 
c) Excluded on the basis of outcomes=4 
d) Did not use a version of Mishel’s IU 
scale=2 
e) Article not written in English=4 
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Note. BAI=Beck Anxiety Inventory (Beck et al., 1988), Brief COPE, (Carver et al., 1989), BSI=Brief Symptom Inventory (Derogatis, 1993), CES-D=Centre for Epidemiological Studies-
Depression (Radloff, 1977), et al., 1997), FARS=Feelings and Reactions Scale (Lemaire, 2004), HADS=Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983), 
IDD=Inventory to Diagnose Depression (Zimmerman & Coryell, 1987), IIRS=Illness Intrusiveness Ratings Scale (Devins et al., 1983),  IUS=Intolerance of Uncertainty Scale (Carleton 
et al., 2007), Locus of control scale-short form (Levenson, 1974), MAX-PC=Memorial Anxiety Scale for Prostate Cancer (Roth et al., 2003), MUIS-A=Mishel Uncertainty In Illness-
Acute (Mishel, 1981), MUIS-C=Mishel Uncertainty In Illness-Community (Mishel, 1986), MSES=Modified Symptom Experience Scale (Detprapon et al., 2009), 
MSPSS=Multidimensional Scale of Perceived Social Support (Zimet et al., 1988), PHQ-9=Patient Health Questionnaire (Kroenke et al., 2001), POMS=Profile of Mood State (Biehl & 
Landauer, 1975), PTSDI=Post Traumatic Stress Disorder Index (Pynoos et al., 1998, cited in Santacroce & Lee, 2007), SCL-90-R=Symptom Checklist-90-Revised (Derogatis, 1992), 
SAS=Zung Self-rating Anxiety Scale (Zung, 1971), SF-GDS=Short Form-Geriatric Depression Scale (Cho et al., 1999), SGS=Short Grit Scale (Duckworth & Quinn, 2009). *p = < 0.05; 






Most of the studies were conducted in the United States of America (N=15). 
Others took place in Canada (N=1), England (N=1), Italy (N=1), Malaysia (N=2), South 
Korea (N=1), Taiwan (N=1) and Thailand (N=1). Three studies recruited participants 
from inpatient settings and the remaining studies from outpatient departments (N=11) or 
community settings (N=9).  
Twenty-two studies employed a cross-sectional design. One employed a 
prospective longitudinal design (Hoth et al., 2013) measuring variables across 2-years. 
All studies used self-report measures. Two studies recruited participants from the same 
medical centre but across different time frames (Pahlevan, 2017a; Pahlevan et al., 
2017b), therefore no overlapping datasets were identified. 
Clinical characteristics 
Demographics 
There was a combined total of 3162 participants across studies and a large 
variation in sample-size (26 to 407, median=118). Mean ages ranged from 19.11 to 65.1 
years with 1919 females and 1243 males. Females constituted 60.7% of the overall 
sample. 
Chronic illnesses 
Twenty-one studies included one CI and 14 CI’s in total were researched across 
the studies, including: childhood onset asthma (Carpentier et al., 2007; Hommel et al., 
2003; Mullins et al., 2017; Mullins et al., 2000; Sharkey et al., 2018; Wolfe-Christensen 
et al., 2008); breast cancer (Pahlevan, 2017a; Pahlevan et al.. 2017b), head and neck 
cancer (Detprapon et al., 2009); lung cancer (Kurita et al., 2013); brain tumours (Lin et 





Kim & J. Kim, 2019); chronic lung disease or COPD (Hoth et al., 2013; Small & 
Graydon, 1992), endometriosis (Lemaire, 2004); hepatitis C (Bailey et al., 2009; 
Colagreco et al., 2014), Multiple sclerosis  (Mullins et al., 2001), Parkinson’s Disease 
(Ahn et al., 2017; Sanders-Dewey et al., 2002) and young adult survivors of childhood 
cancer (Lee, 2006; Santacroce & Lee, 2006). Two studies researched mixed CI 
populations (see Table 1, Mullins et al., 2017; Sharkey et al., 2018). Mullins et al. 
(2017) compared asthma/allergies, mixed CI, and non-CI groups.  
Methodological quality 
All the studies clearly defined their research question, objectives, hypotheses, 
sample population and inclusion/exclusion criteria. Across all studies, independent and 
dependent variables, and their corresponding measures, were clearly defined and 
accompanied by clear reporting of their psychometric properties. The main critique 
pertained to the cross-sectional design (N=22) and limitations associated with this such 
as the inability to make causal inferences and the unmeasurable influence of 
confounding variables on findings. Furthermore, it was only possible to determine that 
>50% of the source population were recruited in 8/23 studies (34.8%). Therefore, for 
most studies, samples were not representative of the source populations. Convenience 
sampling also introduced risks pertaining to self-selection bias amongst the studies. 
Only seven studies (30.4%) reported a power analysis calculation. Therefore, despite 
most studies recruiting large samples, it was difficult to determine if they were 
sufficiently powered to avoid type 1 or II errors.  
Synthesis of review findings 
Studies used a heterogeneous array of measures based on Mishel’s 
conceptualisation of IU, measures of psychological distress; and recruited participants 





given firstly to the overall levels of IU; the general trends across studies of the 
association between IU and psychological distress: and next according to care-context; 
measures of psychological distress; CI types; and ‘other’ variables researched in relation 
to IU. Table 1 presents the correlation coefficients for all the included studies and will 
be used to facilitate comparisons amongst the measures and groups.  Tables 3-5 present 
means and effect size ranges of the groups or measures to further facilitate comparison 
of findings.   
1.What do the studies suggest about the commonality of illness uncertainty in those 
with chronic illnesses and its association with psychological distress? 
Table 2 presents descriptive statistics for IU scores.  
Table 2. 
The means, standard deviations (SD) and ranges of scores for studies reporting the 
most used MUIS-C and MUIS-A 
Measure Mean (SD) Minimum/maximum score 
range 
MUIS-C (possible range 
23-115) 
56.14(7.9) 45.95-70.60 
MUIS-A (possible range 
33-165) 
88.9(6.39) 81.78-99.03 
Note. Nine out of twelve studies using the MUIS-C reported mean IU scores for 
their samples and all five studies using the original 33-item MUIS-A (or variation of) 






Totalled mean scores across the study samples were subjectively interpreted and 
deemed low to moderate. Raw scores from the remaining studies using alternate 
measures (see Appendix F) mirror these findings, suggesting that low to moderate 
levels of IU are consistent across studies. 
Twenty-one studies (91.3%) found statistical significance between IU (or a facet 
of IU) and form of psychological distress in a positive direction, thus the greater the IU, 
the greater the psychological distress. Effect sizes were wide-ranging (r = 0.14-0.82). 
2. Are there differences in the association between illness uncertainty and 
psychological distress according to the care-context? 
The IU measure used reflected the care-context. Illustratively the MUIS-C 
(Mishel, 1991) was used predominantly with community (N=9) and outpatient samples 
(N=2). The MUIS-A (Mishel, 1981) was used in inpatient (N=3) and outpatient samples 
(N=5). 
All nine studies researching community samples found significant associations 
between IU and a form of psychological distress. These studies researched CI’s ranging 
from childhood onset asthma (N=4), endometriosis (N=1), childhood cancer survivors 
(N=2) and mixed CI’s (N=2) (see Table 1). Across studies varying forms of 
psychological distress were researched, including depression (N=8), anxiety (N=5), 
general psychological distress (N=5) and post-traumatic stress symptoms (N=2).  
Carpentier et al. (2009) conducted hierarchical regression analyses and found 
that IU significantly predicted depression, anxiety, and psychological distress 
(p<0.001). Their study was rated as ‘good’ and included a largely representative  
population of college students (92% participant rate) who rated their asthma severity as 
relatively mild and somewhat controllable. From examination of bivariate correlations 





2006; Mullin et al., 2017; Santacroce & Lee, 2006), or large (Hommel et al., 2003; 
Sharkey et al., 2018; Wolfe-Christensen et al., 2009). These studies shared the 
limitation of not controlling for confounding variables in their examination of the 
association, however for those who conducted partial correlations (Hommel et al., 2003; 
Mullins et al., 2000) significant associations remained.  
There was a similar trend towards a significant association between IU and 
psychological distress for inpatient samples using the MUIS-A. Those researching 
chronic end of life renal disease (Barberis et al., 2019; B. Kim. & J. Kim., 2019) both 
found medium effect sizes. Conversely, Small and Graydon (1992) found that IU 
accounted for only 9% of the variance (non-significant) of negative mood in a sample 
with COPD. The authors postulated that the mean length of time since diagnosis (10.6 
years) led to the development of coping, however length since diagnosis was 
comparable to other studies within this review where significant associations were 
found (see Appendix G). However, they used a small sample and did not report a power 
calculation. Thus, the study might have lacked sufficient power to detect an association 
(type 1 or 11 error). 
Outpatients samples (N=11) included those living in the community but 
receiving treatment from a medical centre (inclusive of Parkinson’s disease, multiple 
sclerosis, types of cancers, COPD and Hepatitis C). There was a similar trend towards a 
significant association between IU and psychological distress. Of the significant 
associations found across outpatient samples, the effect sizes were wide-ranging (0.13-
0.82). Two studies found non-significant associations (Kurita et al., 2014; Sanders-
Dewey et al., 2002). However, in Sanders-Dewey et al’s. (2002) study with individuals 
with Parkinson’s disease, the MUIS-C was found to have low internal consistency 





population and thus validity of their findings. Table 3 presents the mean effects sizes for 
all population groups to further aid comparisons. Mean effect sizes for all care-contexts 
fell within the medium range.  
Table 3. 
Effect size ranges, means and standard deviations (SD’s) for the association between IU 
according to care context 
Sample Number of studies Mean effect size 
(SD) 
Range 
Community 9 0.39 (0.20) 0.01-0.63 
Outpatients 11 0.41(0.19) 0.07-0.82 
Inpatients 3 0.36(0.46) 0.31-0.40 
Note: Bivariate correlation coefficients were included in the calculations, however if a 
study only reported partial correlations these were included in the mean effect size 
calculation.  
3. Are there differences in associations between illness uncertainty and psychological 
distress according to the type of measurement of psychological distress? 
Depression was the most widely measured form of psychological distress (N=16), 
Within these studies the CES-D (Radloff, 1977, N=6) was the most widely used measure, 
containing frequency-based questions regarding an array of depressive symptoms. Others 
used subscales of the HADS (Zigmond & Snaith, 1983, N=4), containing items related to 
symptoms of anhedonia. See table 1 for other depression measures used.  
Measures of depression and associated mood states. Across all 16 studies 
researching IU and depression there was a general trend towards significant and positive 
associations, with wide-ranging effect sizes (r=0.05-0.82). Several large effect sizes 
were found between IU and CES-D (Radloff, 1977) (Bailey et al., 2009; Colagreco et 





Three of the studies researching depression used the MUIS-A which illuminated 
the elements of IU within Mishel’s conceptualisation more associated with the 
development of low mood. Ambiguity correlated with depression across several studies 
(Bailey et al., 2009; Colagreco et al., 2014; Hoth et al., 2013). A strength of Bailey et 
al’s. (2009) study was that they controlled for the other IU subscales. Conversely 
neither Bailey et al. (2009) nor Colagreco et al. (2014) controlled for confounding 
variables, meaning other unknown factors could have impacted the association between   
IU and depression. Hoth et al. (2013) also found in their longitudinal investigation that 
depression was associated with ambiguity across a 2-year time-period and not at any 
point in the illness trajectory. This indicates that IU plays a causal role. The authors also 
recruited a geographically diverse sample. Non-significant associations were found 
between the unpredictability subscale and depression in two studies researching people 
with Hepatitis C (Bailey et al., 2009; Colagreco et al., 2014).  
All other studies using depression measures examined the relationship with 
MUIS-total scores. Positive and significant associations were consistent across CI types 
and care-contexts. This was synonymous for negative mood states (Lin et al., 2013), 
however this finding was not consistent (Small & Graydon, 1992). Hommel et al. 
(2003) found that once gender, age, subjective and objective illness severity (asthma) 
were controlled for, the association between IU and depression became non-significant.  
Measures of anxiety. Eight studies measured anxiety using anxiety subscales of 
the HADS (Zigmond & Snaith, 1983, N=4), and BSI (Derogatis, 1993, N=2); the SAS 
(Zung, 1971, N=1), and BAI (Beck et al., 1988, N=1). Effect sizes ranged from small to 
large (0.01-0.56). Most of the studies found positive significant relationships between IU 
and anxiety. Anxiety also remained stable over a 2-year period and correlated with the 





ambiguity/vagueness of symptom profile does not abate. In both Mullins et al’s. (2017) 
and Carpentier et al’s (2009) studies levels of anxiety were significantly higher in the CI 
groups compared with the healthy controls (no CI diagnosis).  
Eight of these studies examined both anxiety and depression. Interestingly, of 
these eight studies, anxiety had larger correlation coefficients than depression in five 
studies (Barberis et al., 2019; Hommel et al., 2003; Hoth et al., 2013; Mullins et al., 2017; 
Sharkey et al., 2018). In Hommel et al’s. (2003) study IU contributed significant variance 
to anxiety once gender, age, disease variables and depressive symptomatology were 
controlled for.  
Measures of psychological distress. Synonymous with low mood and anxiety a 
positive significant association was found across six of the seven studies using measures 
of general distress.  All these studies used the MUIS-C (Mishel, 1991) thus conclusions 
could not be drawn pertaining to individual facets of IU. The effect sizes ranged from 
small to large with a medium overall mean effect size (see Table 4). Two studies 
researched childhood survivors of cancer (Santacroce & Lee, 2006) assessing post-
trauma symptomatology and found medium significant effect sizes. This supports that 
IU remains relevant and associated with trauma symptoms for those who are no longer 
actively unwell but live with an ongoing threat of re-occurrence. Table 4 presents the 
mean effect sizes for all forms of psychological distress. Overall, they all fell within the 











Number of studies Mean effect size 
(SD) 
Effect size ranges 
Depression 17 0.38 (0.17) 0.06-0.82 




5 0.33(0.22) 0.04-0.53 
Post-trauma 
symptoms 
2 0.40(0) 0.40 
Note: Bivariate correlation coefficients were included in the calculations, however if a 
study only reported partial correlations these were included in the mean effect size 
calculation.  
4. Are there differences in associations between illness uncertainty and psychological 
distress according to chronic illness type? 
One study directly compared CI groups (see Table 1, Mullins et al., 2017). Their 
group with mixed CI’s had significantly higher levels of IU and anxiety than those with 
asthma/allergies or those with an absence of  a CI diagnosis. Four studies researched 
childhood onset asthma (Carpentier et al., 2007; Hommel et al., 2003; Mullins et al., 
2000; Wolf-Christensen et al., 2009); and two additional studies researched mixed 
asthma/allergy samples (Mullins et al., 2017; Sharkey et al., 2018). All six of these 
studies recruited young adult college students limiting generalisability to other 
populations. Nevertheless, borderline large or large effect sizes were found in most of 
the studies researching solely asthma or medium or large effect sizes were observed for 
those including mixed asthma/allergy samples. The only study that researched 
endometriosis found IU to be associated with emotional distress with a medium effect 





Positive significant associations were consistently found for those with cancers, 
with at least medium effect sizes (0.27-.0.82). The largest effect size was observed for 
those with head and neck cancer, an illness that threatens parts of the body that are 
visibly prominent and serve important communicative functions. One out of three 
studies researching degenerative conditions (Sander-Dewey et al., 2002) found a non-
significant association. It was possible that those individuals were clearer about their 
prognosis and impending outcome. However more studies are needed on IU and 
degenerative conditions so that robust conclusions can be drawn.  
Table 5 presents the mean effect sizes across CI groups. The mean effect size 
was slightly larger for those with cancers overall, which may reflect the threatening 
nature of the condition and corresponding treatments.  However, all groups fell within 
the medium effect size range.  
Table 5.  
Effect size ranges, means and standard deviations (SD’S) for the association between IU 
according to CI types. 
Sample Number of studies Mean effect size 
(SD) 
Effect size ranges 
Cancers 6 0.43 (0.17) 0.18-0.82 
Childhood onset 
asthma/allergies 
6 0.36 (0.23) 0.01-0.63 
Degenerative 
conditions 
3 0.30(0.16) 0.14-0.47 
Note: Bivariate correlation coefficients were included in the calculations, however if a 
study only reported partial correlations these were included in the mean effect size 
calculation.  
5. What is known about other variables in relation to illness uncertainty?  
Gender. Eighteen studies used mixed gender samples, and seven examined IU 





participants with mixed CI’s and childhood onset asthma (Sharkey et al., 2018; Wolfe-
Christensen et al., 2008). There was no significant difference in IU scores between 
genders in five studies (Ahn et al., 2017; Bailey et al., 2009; Carpentier et al., 2009; 
Kurita et al., 2013; Mullins et al., 2001).  
Illness intrusiveness. Illness intrusiveness was assessed across five studies 
(Carpentier et al., 2007; Mullins et al., 2000; Mullins et al., 2001; Mullins et al., 2017; 
Sharkey et al., 2018). Only one study (Sharkey et al., 2018) found that IU and illness 
intrusiveness combined influenced anxious and depressive symptomatology. The other 
studies found that IU and illness intrusiveness independently predicted depressive and 
anxious symptomatology (Mullins et al., 2000; Mullins et al., 2001; Mullins et al., 
2017). Illness intrusiveness did not mediate the relationship (Mullins et al., 2000). 
Mullins et al. (2017) found greater effects sizes for IU than illness intrusiveness for both 
depressive (β=0.36, p < .001) and anxiety symptoms (β=0.46, p < .001). . 
Grit. Sharkey et al. (2018) found an inverse relationship between grit and IU 
(β= -0.21, p< .05). Their overall path-analysis demonstrated that IU mediated the 
relationship between grit and outcomes of anxiety and depression. Thus, grit was 
associated with reduced IU which in turn was related to decreased distress. 
Coping styles. Pahlevan et al. (2017b) found a significant positive relationship 
between IU and avoidant coping (r = 0.218, p < 0.05), and the inverse for active 
emotional coping (r = −0.297, p < 0.01). Kurita et al. (2013) examined avoidance (e.g. 
of uncertain situations threatening images or thoughts) and its relationship with 
intolerance of uncertainty. Avoidance was found to mediate between intolerance of 
uncertainty and non-somatic depressive symptoms. 
Locus of control. Pahlevan (2017a) examined LOC and found that individuals 





experienced lower anxiety (-0.374, p<0.01) and depression (-0.269, p<0.01). 
Uncertainty mediated the relationship between LOC and depression, but not anxiety.  
Disease-related variables 
Symptom severity. Subjective symptom severity was measured across seven 
studies and objective illness severity was additionally measured in three of those studies 
(see Table 5).  The measures used to examine illness severity differed in accordance 
with differing clinical profiles. Overall, IU was more frequently positively associated 
with subjective ratings, thus the more one perceived their symptoms to be severe the 
greater the IU. A limitation of Wolfe-Christensen et al’s. (2008) study was there use of 
a single item created by the research team, thus calling into question the 






Table 5.  
The Correlation coefficients (r) between subjective and objective illness severity and 
IU. 
Study Subjective illness severity 
rating 
Objective illness severity 
rating 
Carpentier et al. (2007) 0.01 -0.06 
Detprapon et al. (2009) 0.69***  
Hommel et al. (2003) 0.17 0.23 
Mullins et al. (2000) 0.38*  
Mullins et al. (2017) 0.106**  











Wolf-Christensen et al. 
(2008) 
0.40** 0.07 
Note. *p = < 0.05; **p = <0.01; ***p = < 0.001 
Illness duration. Illness durations varied greatly across studies and are 
tabulated in Appendix G. Three out of seven studies that examined illness duration 
found a non-significant association with IU. In two studies ‘time since diagnosis’ was 
used as a control and the significant relationship between IU and PD remained 
(Pahlevan, 2017a; Pahlevan et al., 2017b). In the only prospective study, ambiguity, and 





al., 2013). Only one study found that an earlier point in the illness trajectory was 
associated with greater IU in those with brain tumours (Lin et al., 2013).   
Discussion 
This is the only systematic review to synthesise and examine the current state of 
quantitative research investigating the association between IU and psychological 
distress in adult CI populations. The review comprised 23 papers spanning almost three 
decades (1992 to 2019), with a total number of 3126 participants. Overall low to 
moderate levels of IU were observed across the included studies, confirming that IU is 
an integral aspect of the CI experience (Mishel, 1990). 
This synthesis garners strong support for the association between IU and 
psychological distress, supported by 21 studies. While conclusions cannot be drawn 
regarding the direct or causal link between IU and psychological distress, findings 
suggest IU impacts on psychological distress in adults with CI. This is consistent with 
the meta-analytic evidence found in relation to paediatric IU in which medium effect 
sizes were observed between IU and outcomes of depression and anxiety (Szulxzewski 
et al., 2017).  
IU was ubiquitously linked with psychological distress, regardless of gender, 
care-context, form of psychological distress or CI type. Some findings suggest that 
ambiguity; symptoms or causes that can be vague and interpretable in several ways, 
might be more pertinent to the development of psychological distress than other facets 
of IU. Furthermore, slightly higher associations were found overall for those with 
cancers, with at least medium effect sizes (0.27-.0.82). This might reflect the threat of 
mortaility cancer poses (American Cancer Society, 2008). More research is needed 





This synthesis found that IU associated with diverse manifestations of distress. 
Depression and anxiety were frequently comorbid which reflects findings in the general 
population (Wu & Fang, 2014); and overall, they were consistently associated with IU. 
Clark and Watson’s (1991) tripartite model argues that anxiety and depression which 
are physiologically and phenomenologically distinct (anxiety is characterised by 
hyperarousal and depression by anhedonia), are both underpinned by negative 
affectivity. Comorbidity can complicate the clinical picture, leading to treatment 
resistance (Wu & Fang, 2014). However, these findings suggest that IU is an underlying 
transdiagnostic factor elevating negative affectivity in those with CI’s. Furthermore, 
trauma symptoms were observed to associate with IU in two childhood cancer survivor 
populations (Lee, 2006; Santacroce & Lee, 2003). Post trauma symptomatology has 
also been identified in a chronic heart disease population (Moreland & Santacroce, 
2018), which suggests this finding is generalisable to other CI populations and 
underpinned by IU related challenges. However more research is needed assessing post 
trauma symptomatology in those with other CI’s. 
Theoretical frameworks  
Considering Mishel’s (1990) framework it can be inferred from these findings 
that negative appraisal and maladaptive coping strategies are employed in response to 
the experience of IU, leading to outcomes of psychological distress. Indeed, in Wright 
et al’s. (2009) review IU was found to associate with maladaptive coping strategies. 
Most of the studies did not assess appraisal processes connected to IU, mirroring a 
previous critique of the empirical literature guided by Mishel’s UIT (McCormick, 
2004). However, research has begun exploring intolerance of uncertainty (Kurita et al., 
2013) and ILOC (Pahlevan et al., 2017); the appraisal that one is responsible for the 





how in control a person feels influences uncertainty (McCormick, 2002). Furthermore, 
ILOC has previously been found to inversely associate with anxiety, and depression 
(Fan et al., 2010; Park & Gaffey, 2007) and better health outcomes (Green & Murdock, 
2013). A large body of research has studied intolerance of uncertainty as an influential 
transdiagnostic factor underlying anxiety disorders and depression (Boswell et al., 2013; 
Carleton et al., 2012). Hence, a fruitful area for future research pertains to the 
exploration of intolerance of uncertainty and ILOC as specific appraisal process in the 
context of CI and IU. 
This synthesis indicates that IU correlates with psychological distress at any 
point in the illness trajectory and post recovery, into survivorship (Lee, 2006; 
Santacroce & Lee, 2006). This evidence and the longitudinal investigation (Hoth et al., 
2013) refutes Mishel’s (1990) UIT reconceptualization that, over time, a perspective 
shift from a danger appraisal to opportunity may lead to positive psychological changes. 
However, psychological adaptation to CI and chronic IU is a complex, evolving and 
possibly cyclical process (Mishel, 1988, 1990).  Qualitative research in this area would 
enrich the understanding of how IU is experienced and evolves over time.  
The cognitive behavioural model can also be used to understand the association 
between IU and psychological distress. The theory argues that appraisals, emotions, and 
behaviours (such as maladaptive coping strategies) interact and influence each other. 
Pahlevan et al. (2017b) found that IU was positively associated with avoidant coping 
(such as denial or self-distraction), anxiety and depression, a finding that was consistent 
with previous findings in a sample with prostate cancer (Guan et al., 2020). Pahlevan et 
al. (2017b) adds the importance of IU in this association. The Cognitive Behavioural 
Therapy (CBT) model suggests that the ways in which one behaves (coping strategies) 





strategies, management of affect and cognitive reframing (Beck, 1976). A previous 
study demonstrated that applying CBT and shifting control-beliefs from external to 
internal (ILOC) led to positive outcomes in a CI population (Mehrtak et al., 2017).  
Limitations of the studies  
The limitations of the included studies restrict the validity and generalisability of 
the findings. The predominant limitation concerned the cross-sectional design which 
meant causality could not be deduced. Henceforth it was unclear whether IU contributed 
directly to psychological distress or whether those with higher psychological distress 
experienced greater IU. It might be that there is a reciprocal and mutually reinforcing 
relationship between  these variables. Future longitudinal research should utilise designs 
that elucidate causation and explore the temporal relationships between variables.  
A cross-sectional design also introduces risks pertaining to uncontrolled, 
confounding variables (Setia, 2016). IU and psychological distress are dynamic and 
likely to be confounded by external events. Therefore, caution should be exercised 
when attributing psychological distress solely to IU. Additionally, in relation to 
examination of the direct association between IU and psychological distress, only nine 
studies used statistical methods that allowed for known confounding variables to be 
controlled for. Finally, only six studies reported a power calculation, thus despite most 
studies recruiting large samples, it was difficult to determine if studies were sufficiently 
powered (Nayak, 2010). 
The studies were also limited in terms of their generalisability. Most studies 
were conducted in the USA; thus, the cross-cultural validity of the findings is spurious. 
Additionally, convenience sampling was used across studies. This method can reduce 
sample bias by generating a more representative sample of the population of interest 





were recruited. Thus, in comparison to random sampling methods this design lacks 
rigour. Furthermore, all studies researching childhood asthma or mixed asthma/allergies 
samples used young adult college students and thus future research would need to 
diversify samples to generalise findings. As significant differences between asthma and 
allergy groups have been observed (Hullman et al., 2013), future research should 
delineate groups. Replicated studies of specific CI’s might add to the understanding of 
IU and psychological distress for each CI, which vary naturally in their challenges, 
particularly with regards to the condition’s controllability.  
While a strength of the studies was that they utilised valid and reliable measures, 
Carleton et al. (2013) argued that the validity and psychometric properties of the CES-D 
have been questioned. For example, items assessing somatic concerns may artificially 
inflate scores for chronic pain populations. Considering that the phenomenology of 
many CI’s involves the experience of pain or other somatic complaints, it must be 
acknowledged that this may have conflated findings in the six studies in which it was 
employed in. Future research might consider the use of depression measures that do not 
include items related to somatic complaints. In general, the extensive use of self-report 
measures may have increased the chance of shared method variance which can lead to a 
higher probability of significant relationships between variables (Podsakoff et al., 
2003). With further consideration of measurement, future studies should delineate 
MUIS subscales to assist understanding of which aspects may be a target for 
psychological intervention.  
Limitations of the review 
A narrative synthesis approach was chosen on the basis the studies were not 
homogenous enough to conduct a meta-analysis; it was deemed unfeasible to divide 





this review did not use meta-analytic statistics to quantify associations and test 
moderators, however the narrative synthesis enabled examination of the IU, 
psychological distress association across settings, CI types and forms of psychological 
distress. The conclusions may have been undermined by publication bias meaning that 
quantitative studies that demonstrate significant findings are more likely to be published 
or those that did not are more likely to remain unpublished (Joober et al., 2012). 
Furthermore, the exclusion of grey literature and non-English language articles from the 
review may have increased this bias. Future reviews could include correspondence with 
experts in the field to pursue unpublished data (Rosenthal, 1979). Finally, mean effects 
sizes were used to supplement comparison of groups, however this simple statistically 
calculation does not calculate the precision of individual studies (Borenstein et al., 
2007), thus these findings should be interpreted with caution. 
Strengths of this review included the breadth of electronic databases searched, 
with no publication-date restrictions, enabling a comprehensive search of eligible 
studies. This increased the probability they were all retrieved. This review followed a 
systematic process and employed a critical appraisal tool, second-rated, which increased 
its robustness and would enable other reviewers to accurately replicate. Furthermore, 
the PRISMA (2009) checklist was used to facilitate quality and comprehensiveness (see 
Appendix H). 
Clinical implications 
This synthesised body of evidence does not refute current practices and 
guidance. An intervention employing cognitive-behavioural strategies in line with NICE 
(2010) guidance, suggests that IU can be modified by targeting a patient’s cognitions, 
knowledge, and coping skills and that this can have positive effects for those with a CI 





transdiagnostic factor underpinning many forms of psychological distress is relevant in 
diverse care settings, across genders, and at any time across the illness trajectory.  
HCP’s should routinely assess for the presence of IU and forms of psychological 
distress at the point of diagnosis, throughout the illness trajectory and into survivorship 
(Decker et al., 2007). Use of the MUIS-A would enable assessment of the distinct 
aspects of IU, however when used in community samples, consideration ought to be 
taken with regards to non-applicable items. HCP’s should assess for the idiosyncratic 
meaning of IU, appraisals (including of intolerance of uncertainty and control beliefs) 
and coping strategies. Where psychological distress reaches a clinical level, the above 
assessment information can guide the development of a CBT case formulation 
(Jacqueline & Lisa, 2015) and guides target areas for intervention that account for IU.  
Given the prevalence of IU in CI populations and potential for negative appraisal or 
intolerance of uncertainty, the experience of IU should be normalised. In line with 
Mishel’s (1981) theory and the pertinence of ambiguity to psychological distress, 
HCP’s should endeavour to provide clear information and effective communication. 
Conclusions 
A synthesis of all available studies strongly suggests an association between IU 
and psychological distress, regardless of individual or contextual differences. Findings 
support current guidance recommending CBT to address psychological distress in those 
with CI. IU should be considered as a transdiagnostic factor, and appraisals processes 
targeted. HCP’s should normalise IU in those with CI’s at any point along the illness 
trajectory. Future research is needed to establish appraisal processes linked to IU, causal 
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Search strategy: search terms 
 
Search terms entered into all search engines Scopus, Psycinfo and MEDLINE 
Population Target variable Psychological outcome 
“chronic* ill*” OR 
“chronic condition*” OR 
“chronic* disease*” OR 
“chronically critically ill” 
OR “chronic patient*” OR 
“noncommunicable 
disease*” OR NCD 
OR illness OR disease OR 
“disabled persons” OR 
LTC OR “long term 
condition*” OR arthritis 
OR asthma OR “brain 
injuries” OR cancer OR 
“cardiovascular disease*” 
OR “chronic obstructive 
pulmonary disease*” OR 
COPD OR CVD OR 
“diabetes mellitus” OR 
diabetes OR epilepsy OR 
HIV OR 
hypercholesterolemia OR  
“illness uncertainty” OR 
“Mishel* illness 
uncertainty theory” OR 
“Mishel* illness 
uncertainty scale” OR 



















OR “psychological stress” 
OR depression OR 
“depressive symptom*” 
OR “depressive disorder” 
OR “emotional distress” 
OR “mood state*” OR 
“negative mood” OR 
“negative affect” OR 
anxiety OR anxious OR 
loneliness OR PTSD OR 
“posttraumatic stress 
disorder” OR distress OR 
“psychological well-
being” OR “psychosocial 
adjustment” OR 
“psychological 












disease” OR “interstitial 
cystitis” OR lupus OR 
“musculoskeletal disorder” 
OR “multiple sclerosis” OR  
“parkinsons disease” OR 
“sickle cell disease” OR 
stroke 
  
Note. COPD=chronic obstructive pulmonary disease; CVD=cardiovascular disease; 
HIV=Human immunodeficiency virus; LTC=long term condition; MUIS=Mishel’s 









Search strategy: Inclusion/exclusion criteria  
 
Table presenting inclusion and exclusion criteria 
Inclusion Exclusion 
Over the age of 18 years and individuals 
with a diagnosed chronic health condition 
defined by DOH (2017) and WHO (2016) 
(and defined diagnostically by the 
medical profession) 
 
The paper includes the measurement of 
PD as defined in previous research as a 
broad concept (Gong et al., 2016; 
Kuswanto et al., 2018) 
 
A Quantitative methodology was used 
including cross-sectional, correlational, 
prospective and longitudinal studies. 
 
The direct relationship between IU and 
PD is statistically examined. 
 
Populations with conditions that do not fit 
the definition of a diagnosable chronic 
health condition, such as medically 
unexplained symptoms, chronic pain 
conditions or diagnoses of exclusion (e.g. 
fibromyalgia, chronic fatigue syndrome); 
 
Papers that are studying an acute self-
limiting condition, other non-chronic 
physical health illness or chronic mental 
illnesses 
 
Papers studying participants under age 18 
or where the data is not separate for the 









Inclusion criteria Exclusion criteria 
The paper is published in a peer-
reviewed journal. 
The paper is written in the English 
language. 
IU is measured using a version of or 
subscale of the MUIS (e.g. Hagen et al., 
2011; Mishel, 1981; Mishel, 1986) 
The full-text paper is possible to obtain 
following reasonable means to obtain it  
 
The paper uses proxy measures of 
individual uncertainty (e.g. child illness 
uncertainty, parent uncertainty or carer 
uncertainty) 
Outcomes measures that do not constitute 
PD (see introduction) 
Measurement of IU immediately before 
and/or after participants are undergoing a 
major medical procedure/surgery/drug 
trial. 
Non-peer reviewed papers such as grey 
literature, conference abstracts, case 
studies or unpublished theses 










Psychometric properties of MUIS measures used in the studies included in this review  
MUIS-Acute (MUIS-A, Mishel, 1981) 
The MUIS-A which has been available since 1981 has undergone repeated 
psychometric evaluation (Bailey et al., 2009). Cronbach’s alphas of the four subscales, 
ambiguity (13 items), complexity (7 items), inconsistency (7 items) and unpredictability 
(5 items) were 0.86, 0.81, 0.78 or 0.65 respectively (Mishel, 1997); and a Cronbach’s 
alpha of 0.87 for the whole scale (Mishel, 1997). The full scale MUIS-A was found to 
be 0.90 in a study with those with Hepatitis C (Bailey et al., 2009). The Cronbach’s 
alpha was 0.84 in another study researching those with Hepatitis C (Colagreco et al., 
2014. The Cronbach’s alpha was 0.86 in a study on a population of people with chronic 
renal disease (Barberis et al., 2019). The Cronbach’s alphas for the ambiguity and 
complexity subscales were 0.88 and 0.79 respectively in a study with individuals with 
chronic lung disease (Hoth et al., 2013). 
The 33-item MUIS-brain tumour form (MUIS-BT, Lin et al., 2012).  
Six out of 33 items in the original MUIS-A were modified to better suit the 
experience of people with primary brain tumours and uncertainty. Cronbach’s alphas of 
the four subscales, ambiguity/inconsistency, unpredictability of disease prognosis, 
unpredictability of symptoms and complexity were 0.90, 0.77, 0.75 and 0.65, 
respectively for those with brain tumours (Lin et al., 2012). 
The 33-item Korean MUIS (Jung et al., 2005) 
The Korean MUIS  was found to have a Cronbach’s alpha on 0.91 in people 
with gynaecologic cancer patients (Jung et al., 2005) and 0.79 in a study researching 





MUIS-Community (MUIS-C, Mishel, 1997) 
MUIS-C scores across 18 adult samples with CI’s (total n=1068) were examined 
and Cronbach’s alpha ranged from 0.53-0.92; values exceeded 0.85 in the majority of 
the samples (Mishel, 1997), comparable to the MUIS-A. Bailey et al. (2011) conducted 
a secondary analysis examining the reliability of the MUIS-C for use with men 
undergoing active surveillance for prostate cancer and the Cronbach’s alpha for the full 
MUIS-C was .908. The Cronbach’s alphas collected from 20 studies with people with 
CI’s (Mishel, 1997, cited in Carpentier et al., 2009) ranged from 0.74 to 0.92.  
MUIS-short form (MUIS-SF, Hagen et al., 2015) 
The 5-item MUIS-SF was found to have a Cronbach’s alpha of 0.70 in patients 
with breast cancer. In two studies researching women with breast cancer (Pahlevan, 












Quality appraisal tool 
 
The Observational Cohort and Cross-sectional studies tool (National Institutes of Health 
(2014). Observational Cohort and Cross-sectional studies tool. 
https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools 
 





1. Was the research question or 
objective in this paper clearly stated? 
      
2. Was the study population clearly 
specified and defined? 
      
3. Was the participation rate of eligible 
persons at least 50%? 
      
4. Were all the subjects selected or 
recruited from the same or similar 
populations (including the same time 
period)? Were inclusion and exclusion 
criteria for being in the study 
prespecified and applied uniformly to all 
participants? 










5. Was a sample size justification, 
power description, or variance and 
effect estimates provided? 
      
6. For the analyses in this paper, were 
the exposure(s) of interest measured 
prior to the outcome(s) being 
measured? 
      
7. Was the timeframe sufficient so that 
one could reasonably expect to see an 
association between exposure and 
outcome if it existed? 
      
8. For exposures that can vary in 
amount or level, did the study examine 
different levels of the exposure as 
related to the outcome (e.g., categories 
of exposure, or exposure measured as 
continuous variable)? 
      
9. Were the exposure measures 
(independent variables) clearly defined, 
valid, reliable, and implemented 
consistently across all study 
participants? 
      
10. Was the exposure(s) assessed more 
than once over time? 










11. Were the outcome measures 
(dependent variables) clearly defined, 
valid, reliable, and implemented 
consistently across all study 
participants? 
      
12. Were the outcome assessors blinded 
to the exposure status of participants? 
      
13. Was loss to follow-up after baseline 
20% or less? 
      
14. Were key potential confounding 
variables measured and adjusted 
statistically for their impact on the 
relationship between exposure(s) and 
outcome(s)? 
      
  
  
Quality Rating (Good, Fair, or Poor) 





Quality Rating (Good, Fair, or Poor) 
Rater #2 initials: 
Additional Comments (If POOR, please state why): 






 Quality appraisal of all studies 
 
Table of Quality appraisal ratings for each item on the observational cohort and cross-sectional studies appraisal tool (items 1-14, see Appendix D).  
 


























































et al. (2007) 










et al. (2014) 
 
 
       
NA 




























Hoth et al. 
(2013) 
       
NA 





















































































































































































































Note. Numbers 1 to 14 correspond to quality appraisal tool questions (see Appendix D); Green = Yes   Red = No White = NA/NR/CD. A “good” study 
has the least risk of bias; the results are considered to be valid. “Fair” constitutes some susceptibility to bias but not sufficient to invalidate the result.  








Illness uncertainty scores 
Table presenting IU raw scores for each paper 




































et al. (2007) 
NR    
Colagreco et 
al. (2014) 
 86.45 (13.84)   
Detprapon 










   
Hoth et al. 
(2013) 











90.00(11.63)   





 NR  
Lee (2006) 51.3(14.5) 
 































Lin et al. 
(2013)** 

















   











Other CI’s: 60.34 
(15.26) 
   
Pahlevan 
(2017a)* 
   *NR 
Pahlevan et 
al. (2017b)* 




Dewey et al. 
(2001) 














  77.23(13.89)  
Wolf-
Christensen 
et al. (2008) 
NR    






Time since diagnosis/illness duration figures 
Table presenting TSD figures reported from each paper 
Study Time since diagnosis - mean (years) or 
related information 
Ahn et al. (2017) 7.12 
Bailey et al. (2009) NR 
Barberis et al. (2019) NR 
Carpentier et al. (2007) 6.8(SD=3.85). 
Colagreco et al. (2014) 4.45(range 1.08–8.59) 
Detprapon et al. (2009) The authors reported: 
Almost half (42.5%) had been treated 
using a combination of surgery and 
radiotherapy for 1 - 12 months (mean = 
5.27 months). 
Hommel et al. (2003) 13.63(SD=3.65) 
Hoth et al. (2013) 12.1(SD=7.5) 
B. Kim & J. Kim (2019) NR 
Kurita et al. (2013) NR but inclusion “diagnosed for a 
minimum of 6 months with cancer of the 
lung” 
Lee (2006) The mean time since diagnosis was 16 
(SD = 6.4) years; range 5-31 years 
Lemaire (2004) NR 
Lin et al. (2013) NR 
Mullins et al. (2000) The authors reported: 
Age range of participants (18-25, 19.67, 
SD = 1.77) – they received a diagnosis of 
asthma prior to 12 years of age 





Study Time since diagnosis - mean (years) or 
related information 
Mullins et al. (2017) NR 
Pahlevan (2017a) Means NR 
Pahlevan et al. (2017b) Means NR 
Sanders-Dewey et al. (2001) 6.5 years (SD = 3.8 years). 
Santacroce & Lee (2006) 14.2(SD=6.1) *time since treatment 
completion, childhood cancer survivors 
Sharkey et al. (2018) NR 
Small & Graydon (1992) 10.62(SD=12.02). 
Wolfe-Christensen et al. (2008) All participants received a diagnosis of 
asthma during childhood (age at diagnosis 
ranged from 1 to 12 years old) Mean age - 
19.70 (SD= 1.25) 








 Prisma checklist 






Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  p.1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
P’s. 2-3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  P’s 8-9 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
p.9-10 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
p.10 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
P’s.9-12 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
p.10 




Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
p.11 p.15 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 






Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
p.15 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 





Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  P’s. 27-37 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 





Section/topic  # Checklist item  Reported on 
page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 




Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
n/a 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
p.14-.15 
*PRISMA 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
P’s. 14-25 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  P. 26 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 






Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  n/a 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  n/a 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
n/a 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance 
to key groups (e.g., healthcare providers, users, and policy makers).  
P’s. 38-44 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
P’s. 41-43 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
P’s. 43-44 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for 















Section Two: Research Report 
 
 












In response to an under-developed research field in relation to Inflammatory Bowel 
Disease (IBD) and resilience, this study aimed to develop a theoretical and empirically 
informed understanding of resilience in people with IBD by exploring the factors that 
associate with it.   
Design 
A sequential mixed-method cross-sectional design was employed. 
Method 
Participants over 18 years with self-reported IBD diagnoses were recruited via social 
media advertisements, a volunteer research database at the University of Sheffield, and 
the Crohn’s and Colitis UK website. Five participants were interviewed about their 
resilience experiences and data were thematically analysed. Eighty-five participants 
completed an online survey comprising measures of illness cognitions; social support, 
coping-efficacy, and illness-acceptance; control beliefs and intolerance of uncertainty; 
grit; time since diagnosis, IBD-subtype, disease activity and resilience.  
Results  
Grit was interpreted from the qualitative data, but correlation analyses revealed a non-
significant association with resilience. Time since diagnosis and IBD-subtype also did 
not correlate with resilience. A hierarchical regression revealed that disease activity 
negatively predicted and explained 15.7% of the variance in resilience. Illness-





acceptance, social support and coping-efficacy explained a further 54.1%. Control-beliefs 
and intolerance of uncertainty predicted a further 10.8% of the variance in resilience. 
Conclusions  
Illness cognitions and beliefs about controllability predict resilience over and above the 
negative influence of disease activity. Rather than perseverance towards long-term goals 
(grit), daily persistence or endurance might be more pertinent to resilience in those with 
IBD. Future research should examine causal pathways and the mediating influences of 
the constructs explored in this study between disease activity and resilience. 
Practitioner points 
• Targeting illness cognitions using cognitive behaviour therapy may foster 
resilience. Professional support could be particularly beneficial when disease-
activity is high. 
• Consideration could be taken to target intolerance of uncertainty and third-wave 
therapies could be considered to foster acceptance. 
Limitations  
• The qualitative phase comprised a homogenous sample limiting transferability of 
the findings.  
• A cross-sectional design excludes causal explanations. 
• The validity of  the scales measuring control-beliefs and coping-efficacy were 
compromised and their findings should be interpreted with caution. 
Keywords: Inflammatory Bowel Disease, illness-cognitions, control-beliefs, disease-
activity, grit, mixed-methods.  





Factors that associate with resilience in people with IBD 
IBD is a chronic illness (CI) and umbrella term for inflammatory conditions of 
the digestive system. Subtypes include Ulcerative Colitis (UC) and Crohn’s Disease 
(CD) which affect the large intestine and other parts of the digestive tract respectively 
(NICE, 2015). Indeterminate IBD is diagnosed where diagnostic tests are indicative of 
IBD, but when CD or UC are indistinguishable (Guindi & Riddell, 2004). An estimated 
620,000 people in the UK (0.5-1%) have IBD (Molodecky et al., 2012) and 6.8 million 
globally (Global Burden Disease Collaborators [GBD], 2020). IBD is incurable and 
debilitating, presenting individuals with psychological challenges associated with 
unpredictable relapsing/remitting symptomatology (Moum et al., 1996). IBD subtypes 
share a similar symptom profile, including diarrhoea, faecal incontinence, fatigue, and 
abdominal pain (Bielefeldt et al., 2009; Larsson et al., 2008).  
Research about people with IBD confirms it associates with negative 
psychopathological outcomes including depression and anxiety (Goodhand et al., 2012; 
Todorovic, 2012; Walker et al., 2008), psychological distress (Larsson et al., 2008; 
Nordin et al., 2002) and deleterious effects on quality of life (QOL, Bennebroek et al., 
2012; Casellas et al., 2002). IBD is episodic in nature and is known to disrupt social 
activities, employment, relationships (Kemp et al., 2012; Restall et al., 2016), personal 
goals and functioning (Graff et al., 2009).  
Resilience as a reported and desired state in those with IBD (Fourie et al., 2018; 
Luo et al., 2019) has been less researched (Luo et al., 2019; Sirois & Hirsch, 2017) and 
is under theorised in IBD populations. Research theorising resilience in the context of 
other CI’s has measured the construct as absence of psychopathology and preservation 
of QOL (Stanton et al., 2007; Stewart & Yuen, 2011). An IBD study by Kiebles et al. 





(2010) theorises resilience as retaining psychological/emotional functioning; but in this 
study a specific measure of resilience was not used. As a desired outcome at both an 
individual and clinical level, this research sought to empirically explore resilience 
factors in an IBD population to develop a theoretical understanding of resilience 
specific to IBD. 
Resilience factors in chronic illness and IBD 
Definitions of resilience vary substantially (Davydov et al., 2010), however, 
there is some consensus that it constitutes a return to pre-illness functioning (Gheshlagh 
et al., 2016; Carver, 1998). Carver’s (2010) generalised model of resilience in contexts 
of trauma and adversity distinguishes between deterioration (loss, depression), 
‘bouncing back’ (a return to pre-illness functioning) and thriving (benefit and growth). 
A return to pre-illness functioning is influenced by illness cognitions (beliefs about 
illness and coping resources) that can mediate between the condition and individual 
well-being (Evers et al., 2001; Heijmans & De Ridder, 1998; Scharloo et al., 1998). One 
such illness cognition is self-efficacy and has been posited as one of four functions of 
resilience (Rutter, 1987). Pioneer of self-efficacy, Albert Bandura (1977; 1997) posited 
that it is one’s perception of their capability to execute the necessary behaviours to 
manage situations. 
Other key psychological factors are identified as theoretically and empirically 
linked with  resilience in the literature. Carver (1998) argued that those who thrive do so 
because they develop efficacious strategies for coping. Coping-efficacy which 
associates with thriving in those with arthritis and IBD (Sirois & Hirsch, 2013; Sirois & 
Hirsch, 2017) pertains to appraisals of how successfully one copes (Gignac et al., 2000). 
Furthermore, illness-acceptance; the recognition and willingness to adapt and tolerate 





the unpredictable, uncontrollable nature of the disease (Evers et al., 2001) is an illness 
cognition found to positively correlate with QOL (Kurpas et al., 2013; Lewko et al., 
2012); adjustment and resilience in IBD populations (Kiebles et al., 2010; Sirois & 
Hirsch, 2017). 
Irrespective of IBD’s association with a lower sense of control (Graff et al., 
2009), research pertaining to control-beliefs, IBD and outcomes is limited.  The locus of 
control (LOC) construct (Rotter, 1975) refers to the expectancy belief about control 
over an outcome (Green & Murdock, 2013). The belief in individual responsibility for 
events that occur is termed internal LOC (ILOC, Rotter, 1954). The modified social 
learning theory (Wallston, 1992) purports that health behaviour is contingent on one’s 
perceptions of control over health, synonymous to the construct of coping-efficacy. 
Bandura’s (1977) social cognitive theory additionally argues that one intrinsically seeks 
to exert control over their coping behaviour. ILOC has been linked to better 
psychological outcomes in those with health conditions (Lenze et al., 2008; Panagiotou 
et al., 2014) and decreased anxiety and depression (Fan et al., 2010; Park & Gaffey, 
2007). Qualitative findings report control issues and powerlessness as central tenets of 
the IBD experience (Devlen et al., 2014; Dibley et al., 2017; Dudley-Brown, 1996; Pihl-
Lesnovska et al., 2009).  
How in control one feels also influences uncertainty (McCormick, 2002). 
Uncertainty is pertinent for those with IBD given its unknown aetiology, fluctuating and 
unpredictable symptomatology, thus the ability to tolerate uncertainty is an important 
factor. Intolerance of uncertainty (IOU) refers to the propensity to react negatively to 
uncertain situations (Buhr & Dugas, 2009) and has been conceptually and empirically 
linked to generalised anxiety disorder (GAD, Dugas et al., 1997) and lower 





psychological adjustment in those with lung cancer (Kurita et al., 2013). Higher 
perceived certainty has been linked to better QOL in one IBD study (Niv et al., 2017), 
however, the relationship between IOU and resilience has never been examined in an 
IBD population and thus is not understood.  
Social support has been found to lead to positive outcomes in those with IBD. 
Received support is distinct from perceived support (Kamp et al., 2019), which is the 
realisation of being accepted and cared for (Strom & Egede, 2012); another illness 
cognition. The protective function of social support has been well documented (Ozbay 
et al., 2008). Theoretical models of social support acknowledge the importance of both 
emotional (receiving love and empathy) and practical components (Charney, 2004) 
through exerting positive effects on multiple neurobiological pathways and fostering 
effective coping (Ozbay et al., 2008). Social support also positively correlates with 
illness acceptance (Janowski et al., 2012) and self-efficacy (Wang et al., 2015).  
In IBD populations, research demonstrates a link between increased social 
support, improved QOL (Janke et al., 2004; Katz et al., 2016); and adjustment in 
patients with IBD cross-sectionally (Gick & Sirois, 2010) and longitudinally (Oliveira 
et al., 2007). However, the relationship with outcomes in IBD is complex as tensions 
such as unwanted confrontation and undesirable reactions can occur (Palent & Himmel, 
2019). This suggests more research is needed to understand the relationship between 
social support and resilience in those with IBD. 
Setbacks are inherent within IBD population given its relapsing/remitting 
symptom profile. Hence, grit may be important to resilience in those with IBD, 
conceptualised as a dimension of resilience (Stoffel & Cain., 2018), which comprises 
perseverance towards long term goals with sustained commitment despite setback and 





adversity (Duckworth et al, 2007). Those individuals possessing grit approach 
threatening situations with assurance they can exercise control over them (Duckworth et 
al., 2007).   
Disease-specific factors   
Disease-specific factors also associate with resilience but research outcomes 
present mixed findings. The relationship between IBD subtypes and psychological 
functioning are variable (Graff et al., 2006; Rubin et al., 2004). Little is known about 
what the impact of time following IBD diagnosis is on resilience, however the time-
period around diagnosis has been associated with higher rates of anxiety and depression 
(Munkholm et al., 1995). Furthermore, distress levels fluctuate in parallel with disease 
activity (Casellas et al., 2005; Porcelli et al., 1996). Greater illness severity has been 
associated with poorer psychological adjustment (Voth & Sirois, 2009) which may link 
to its influence on sense of mastery, the sense that one has control of one’s life (Graff et 
al., 2009). Those in remission were found to have greater perceived control and 
exhibited less depression (Gandhi et al., 2014). In a review of disease activity in CD, ten 
studies revealed an inverse relationship between health related QOL and disease activity 
(Vander-Have, 2014). Research suggests greater disease activity negatively affects 
resilience in IBD populations, however more research is needed. 
Despite constituting a relatively small field, the relationship between IBD and 
resilience is supported by the literature. One IBD study using a small sample found that 
illness-acceptance and coping associated with emotional and psychological functioning 
(Kiebles et al., 2010). A recent study (Sirois & Hirsch, 2017) based on Carver’s (1998) 
resilience framework measured loss, resilience, or thriving. Higher levels of coping-
efficacy, illness-acceptance and social-support were associated with resilience and 





lower levels of depression across domains of life satisfaction, personal growth, and 
relationship quality. However, this study did not use a specific measure of resilience or 
incorporate examination of disease activity.  
Study aims 
This study aimed to develop an understanding of resilience in an IBD population 
based on the key psychological constructs discussed, informed by Carver’s (1998) 
conceptual resilience framework. This research used a mixed-methods design to elicit 
qualitative and quantitative evidence to underpin a robust theoretical model. This study 
aimed to address gaps in current knowledge by examining additional variables in 
relation to resilience, including IBD subtype, time since diagnosis (TSD), IOU, control-
beliefs and understanding of the role of disease activity. The experience of thriving 
(Carver, 1998) was not incorporated because outcomes of ‘bouncing back’ better reflect 
the objectives of recovery focused clinical services aiming to foster resilience (pre-
illness functioning) in the context of limited fiscal resources. 
Clinical implications 
The new empirically informed, theoretical understanding developed in this study 
has important clinical implications. NICE (2010, guideline 91) recommend cognitive 
behavioural therapy (CBT), for the treatment of depression in those with CI’s. However, 
there remains a lack of understanding of how psychological processes strengthen 
resilience (Timmer et al., 2011) as a desired outcome, particularly in IBD populations. 
These findings will enable the tailoring of intervention strategies so important factors 
may be nurtured in those with IBD who are in need (Luo et al., 2019).  
 







A sequential mixed methods design was employed (Creswell et al., 2003), 
whereby the personal, lived accounts of resilience experience, elicited via interviews 
(phase A), confirmed, and extended findings in the existing literature and informed 
additional constructs to be examined statistically in an online survey (phase B). 
Interviewed participants also commented on the usability of the survey (Appendix 
A).  The survey contained self-report measures enabling statistical examination of the 
associations between the variables and resilience. A mixed-methods approach draws on 
the strengths of each data type (Halcomb & Hickman, 2015), by foregrounding both 
participant’s voice and statistical examination of associations between constructs. 
Epistemological position 
The researcher and study approach were oriented towards critical realism as a 
philosophical and methodological framework (Fletcher, 2017). Aligning with the 
mixed-methods design, critical realism combines components of positivist and 
constructionist paradigms but deviates from both in its position that ontology (the nature 
of reality) is not reducible to epistemology (knowledge of reality) (Fletcher, 2017). 
Empirically, events can be measured and observed but only understood through the 
filter of human experience, thus, the researcher’s interpretation was influenced by her 
own unique experiences, beliefs, and values. Therefore, subjective interpretations can 
differ according to individual data-analysts (Madill et al., 2000).  
The researcher arrived at this positioning from her previous experiences of 
training in the Clinical Psychology field and learning to deliver Cognitive Analytic 





Therapy (CAT, Ryle, 1999) which is underpinned by attachment and cognitive, 
behavioural theories (Beck, 1976; Bowlby, 1969; Freud, 1900; Kernberg, 1975; 
Watson, 1913; Winnicott, 1960). CAT focuses on how emotional and relational patterns 
underlie one’s current experiences or difficulties. The researcher was concurrently 
immersed in other psychological theories relevant to resilience and related constructs 
which underpinned the analysis (Bandura, 1977; Carver, 1998; Duckworth et al., 2009; 
Rotter, 1987). Indeed, the researcher understood theoretical and evidence informed 
knowledge of IBD but had no lived experience of it. Combined, these experiences 
exerted an influence on the data being interpreted through a relational lens and with 
preconceived ideals related to positive psychological processes and outcomes.  
Ethics 
The study was designed in accordance with the British Psychological Society 
Ethical Guidelines (2018) and the British Psychological Association Code of Human 
Research Ethics (2014). Ethical approval for the study was obtained from the Sheffield 
University Ethics Committee who provided research governance sponsorship (Appendix 
B). 
Phase A: Qualitative enquiry 
Recruitment 
Purposive sampling methods were employed intending to recruit enough 
participants that met specified inclusion criteria, to attend a focus-group. A group size 
of 4-8 has been argued to be suitable for exploring a range of participant experiences 
(Krueger & Casey, 2015). Advertisements were disseminated electronically via social 
media platforms, Twitter and Facebook and a database containing email addresses from 
volunteer research participants held by the University of Sheffield. Only two 





participants attended a joint interview due to participant constraints and logistical 
challenges thus a design amendment was subsequently developed to elicit participant 
views via individual interviews; a methodology that enabled study aims to be achieved. 
The amendment was ethically approved. Three participants who had expressed interest 
in participation in the focus group but who could not attend were invited to participate 
in individual interviews. One was face-to-face and two via telephone interviews.  
Participants 
To be eligible to participate, participants needed to be over 18 years with a 
confirmed diagnosis of IBD, including IBD indeterminate.  
Procedure 
Participants who agreed to be interviewed were electronically sent an 
information sheet (Appendix C) and consent form (Appendix D). Signed consent forms 
were collated prior to the interviews. Three participants were interviewed on University 
of Sheffield premises, conducted by the main researcher. A semi-structured interview 
schedule was developed by the researcher, guided by thematic analysis (TA) and 
qualitative IBD literature (Braun & Clarke, 2013; Luo et al., 2019). Questions were 
designed to be flexible, with suggested prompts including questions like “are there any 
psychological factors that you feel have affected your resilience?” (see Appendix E for 
interview schedule).  
Those who opted for telephone interviews provided audio-recorded verbal 
consent and consent forms were electronically signed by participants. Interviews lasted 
37-64 minutes (average 54.7 minutes) and were conducted in August/September 2019.  
Participants were offered a £10 voucher for their participation. Another clinical 
psychology doctoral trainee observed the focus group and took notes to aid accurate 





transcription and offer additional insights. All interviews were audio-recorded and 
anonymously transcribed (using pseudonyms) verbatim by the researcher.  
Qualitative analytic method 
TA was employed and data were analysed in an inductive way, enabling themes 
to emerge from the data (Braun & Clark, 2006; Patton, 1990). TA is a flexible approach 
to data-analysis and can be conducted within both realist/essentialist and constructionist 
paradigms, conducive with the critical realist epistemological position (Braun & Clarke, 
2006). Indeed, the researcher supports the realist idea that some forms of “truth” exist 
and interview data offered opportunity for participants to share part of their perceptual 
reality. However, it was acknowledged that one’s understanding of others’ realities 
cannot be fully achieved (Willig, 2008). Braun and Clarke’s (2006) 6-step process was 
undertaken and revisited in a recursive process (see Appendix F), leading to the 
culmination of themes. 
Reflexivity 
The researcher recognised herself as an active part of the research process. To 
bring to conscious awareness the influence of the researcher’s assumptions on the 
interpretation of data (Brocki & Wearden, 2006), the transcripts were repeatedly 
revisited to ensure the codes and themes were rooted in the data. Input was also derived 
from another researcher who had observed and given her interpretations of the focus 
group data. Furthermore, research supervisors (who are also Clinical Psychologists) 
were involved in theme generation and the researcher’s reflections were discussed to 
facilitate consideration of her influence on the interpretation.  
 
 






An analysis and interpretation of data is presented. All participants identified as 
white British females and considered themselves in remission. Their ages ranged from 
22-49 years (mean 34) and disease duration ranged from 2-28 years (mean 10.8). They 
reported diagnoses of CD (n=2) and UC (n=3). They discussed times that their 
condition caused distress and felt difficult to endure. Remission was frequently 
associated with reduced distress and a sense of increased resilience. The perception of 
themselves as resilient was evident, however it was a dynamic state. 
Two superordinate themes emerged, each comprising three subordinate themes 
(Table 1). Themes are discussed and accompanied by illustrative quotes (see Appendix 
G for further supporting quotes). Resilience was characterised by ambivalent states; 
defined as simultaneously holding conflicting feelings or reactions (Schneider & 
Swartz, 2017). Themes comprised intrapersonal (within the mind) and interpersonal 
processes (occurring relationally). How participants managed the inherent tensions 













Table 1  
Summary of superordinate and subordinate themes 
Superordinate themes Subordinate themes 
1. Intrapersonal ambivalence: Grit 1.1 “I quite like the control” 
  
 1.2 “An invisible illness” 
  
 1.3 Carry on regardless”. 
 
2. Interpersonal ambivalence: 
Social support 
2.1 “The support really helps” 
  
 2.2 “Nobody really understood” 
  
 2.3 “brave face” 
 
Themes 
1. Superordinate theme: Intrapersonal ambivalence, grit 
‘Grit’ permeated the discourse; namely the need for diligent engagement with long-
term goals (social and occupational) to maintain resilience. Participants reclaimed control 
by coping independently which boosted resilience, but a conflict occurred when this led 
to the legitimacy of the condition and its severity being questioned. Endurance, a 
regulatory strength, persisting diligently when presented with difficulty (Hamby et al., 
2013) was adopted. This created mixed emotions and either positively or negatively 
impacted resilience.  





1.1 “I quite like the control” For all participants, IBD challenges were buffered 
through reclaiming perceived control. This was achieved by managing the condition 
autonomously in variable ways. This prevented a potential deterioration in their mental 
state which boosted resilience. One way of regaining control was through positive risk-
taking and making disparate decisions to medical professionals to stay on track with 
valued goals. The ability to manage independently and work towards goals (social and 
occupational) generated feelings of  satisfaction and pride: 
“If I had no way of helping me control it myself I would  feel a bit hopeless, I 
quite like the control…….….I think without being able to manage it for myself I would 
struggle to be okay about it.” (Harriet) 
“the satisfaction that I’m managing it myself and actually its working really 
well.” (Annie) 
  1.2 “An invisible illness” The internal conflict around autonomous management 
was that the legitimacy of the condition and its severity came under question. One 
participant discussed relief at the point of diagnosis as it validated the legitimacy of her 
symptoms. The perception that others might think the symptoms to be spurious or 
exaggerated threatened identity, causing difficult emotions, negatively impacting 
resilience. 
Grit encompassed personal goals related to maintaining integrity, and a premorbid 
identity as a fully functioning, able-bodied, genuine individual. This conflict was 
variably managed. Most of the participants subscribed to the non-disclosure view due to 
anxieties about looking weak or burdening others. While this temporarily boosted 
resilience, the lack of openness about the impact of the condition meant that participants 
endured their symptoms alone, lessening resilience. Conversely, one participant opted 





for full public disclosure, motivated by anger. She self-preserved by attempting to prove 
or demonstrate teleological evidence of the severity of the experience.  
 “The frustration……that some people are questioning whether it’s as bad as you’re 
making out.” (Annie) 
“I was pissed off at people, when you’ve got an invisible illness, you tend to get 
people thinking she’s making it up or exaggerating…….that was horrendous and I 
genuinely think that was the worst part” (Sarah) 
“No one’s asking me if I’m alright but I’m just thinking none of these people 
around me understand what I’m going through right now and that can be hard.” 
(Claire) 
         1.3 “Carry on regardless”. Endurance was illuminated by phrases such as “not let 
it beat me” and “bouncing back you’ve just got to”. These participants strived towards 
an imagined life trajectory prior to their IBD diagnosis, demonstrating commitment to 
activities valued by them and wider society. This was underpinned by a fear of loss in 
some cases. Differing internal coping strategies were employed to achieve endurance, 
including “ignorance”, and following a period of loss and grief; “acceptance”. 
“I made myself do everything and I still went to work everyday……mentally really 
didn’t wanna be there but, I force myself.... I’m ignorant because I’m like no I’m fine, just 
gotta carry on” (Claire) 
“If I’m having a flare up it’s not going to stop me from going out there, doing my 
socialising, having plans that I’ve already made….…...I just keep pushing through.” 
(Harriet) 





“When you reach the acceptance you have to look at how you live your life from 
now on……keep looking forward so, you might end up in a better place than you 
thought you were headed anyways.” (Sarah) 
2. Superordinate theme: Interpersonal ambivalence, social support 
Actual or perceived social support impacted resilience. Participants desired support 
that was empathic and boundaried, which enhanced resilience. However, a conflict arose 
from the fear or reality of receiving negative reactions, being misunderstood, judged, or 
stigmatised. To avoid this eventuality, participants put on a “brave face” which 
simultaneously benefited and disadvantaged resilience. This was interpreted as stoicism; 
“silent endurance, lack of emotion……a ‘stiff upper lip” (Moore et al., 2012, p.159-160). 
All participants described parents, family, and close friends as their main 
sources of support. In line with autonomous management of the condition, there were 
mixed feelings towards medical professionals who were viewed as either helpful or a 
hindrance, contingent on their availability and expertise.  
2.1 “The support really helps” All participants desired support in the form of 
an inherent understanding, thus others who had a realistic understanding and ability to 
provide empathic care were valued. This enabled frank conversations about their 
experiences and reciprocal support. This enhanced resilience by helping emotional 
management of the condition. However, it was important that the care received had 
limits so that it was not a threat to their identity. When participants felt “ pandered too” 
(Claire) or wrapped “in cotton wool” (Harriet) this undermined their perceived 
competence. Empathy was desired but an encouraging approach that honoured their 
self-efficacy was imperative. 





“I think the support really helps me being able to manage…the negative emotional 
effects the disease can have and that’s the importance of support.” (Harriet) 
“ I feel like I handle it quite well, I don’t want someone to pander to me………. 
they’re supportive, they’re not feeling sorry for me because that’s not what you want.” 
(Claire) 
2.2 “Nobody really understood”. Their need for closeness was accompanied 
by a fear of being misunderstood or dismissed. Others lacked understanding or 
knowledge or there was a felt stigma about being ill and a taboo around IBD. The 
impact of enduring an experience misunderstood by others had profound effects on the 
ways in which participants related to others. The perceived or real experience of others 
misunderstanding created difficult emotions which led to a reduced sense of resilience. 
Anger that one participant felt at experiencing severe pain and fatigue that was not 
acknowledged by those around her, led her to develop an online support forum. 
However, participants also managed this by dismissing others in varying ways. This 
included choosing to not “let them in”; to initiate intimacy with new people or share 
experiences. Creating this ‘safe’ distance temporarily supported resilience, however in 
the long-term this compromised intimacy and restricted a social network of supportive 
individuals, hindering resilience. For others, an intolerance of others’ lack of 
understanding was manifest or a minimisation of others’ experiences of suffering. A 
self-perception as being comparatively ‘strong’ temporarily boosted resilience as it 
defended against the perception of themselves as vulnerable. However, this perpetuated 
a sense of distance from others which depleted their sense of resilience. 
             “Nobody was listening, or nobody really understood what I was going through 
and that really pissed me off.” (Sarah) 





“Brought out a less tolerant side of me……….others might say, you know, my 
goldfish died (laughs) and that’s where I have less empathy with that situation.” (Sally) 
“Some people wallow in being a victim of something.” (Annie) 
          2.3 “Brave face”. The interpersonal conflict was resolved through the concealment 
of their struggles, stoicism. This enabled resilience as it facilitated self-preservation, 
however, it brought about conflicted feelings. An underlying anxiety and guilt about 
letting others down led to avoidance of self-care such as taking time off sick from work 
(linking to endurance). Participants engaged with stoicism with resentment and 
frustration that perpetuated their aloneness. This reinforced the lack of acknowledgement 
from others, which negatively impacted resilience in the long term. There was recognition 
that stoicism was unsustainable and when expected by others it brought about anger, 
lessening a sense of resilience. 
“I’d be fine on the outside to most people then internally it’d be really shit….” 
(Claire) 
“Tend to just brush it off and go with I’m fine.” (Sarah) 
 “I had a fury and said I’ve got a life-long life changing chronic condition you 
might be allowed to feel a bit sorry for yourself.” (Annie) 
Data analysis summary 
The data revealed key factors that have been previously associated with 
resilience in those with CI’s and IBD. Central tenets of resilience pertained to coping 
independently, perceived control and social support. There was also reference to 
uncertainty, acceptance, and the influences of disease activity; higher disease activity 





was associated with reduced resilience. TSD evoked mixed feelings. The construct of 
‘grit’ also emerged. 
Phase B: Quantitative enquiry 
Recruitment and Procedure 
The recruitment methods were the same as phase A. This phase was additionally 
advertised through Crohn’s and Colitis UK’s website (see Appendix H). Participants 
from Phase A or expressed interest but could not participate for logistical reasons were 
emailed a weblink to the Qualtrics online survey. The information sheet and consent 
were contained within the weblink (Appendix I). Data were collected from 30th January 
until 15th March 2020. Data collated after this was deemed to be influenced by Covid-
19 circumstances and was thus excluded from the analysis. Participants were able to 
enter a £25 vouchers prize draw. 
 
Quantitative measures 
Screening and demographics information.  
The online survey contained screening questions pertaining to age and 
confirmation of IBD diagnosis. The survey contained demographic and IBD-related 
questions (including age of diagnosis, subtype, relapse/remission status) and the 
following self-report measures (see Appendix J). For all measures higher scores indicate 
greater levels of the constructs. A full-scale, total score was analysed for all measures 
except the Illness Cognition Questionnaire (ICQ; Evers et al., 2001). The internal 
consistency scores (α) for each measure in the current study ranged from acceptable to 
excellent (.78 - 93, see Table 4). 
Connor-Davidson Resilience Scale (CD-RISC, Connor & Davidson, 2003).  





The 25-item CD-RISC was designed to assess the personal characteristics that 
embody resilience, including self-efficacy, patience, optimism, faith, personal 
competence, trust/tolerance/strengthening effects of stress, acceptance of change and 
secure relationships and evaluates items on a 5-point Likert scale from 0 “not true at all” 
to 4 “true nearly all of the time” (scoring 0-100). The internal consistency was found to 
be good (α =0.89) in a sample of individuals with generalised anxiety disorder and post-
traumatic stress disorder (Connor & Davidson, 2003).  
Short Health Scale (SHS, Hjortswang et al., 2006, in Mcdermott et al., 2013).  
The 4-item SHS is a proxy measure of disease activity capturing health-related 
QOL. The SHS comprises 4x100mm analogue scales assessing symptom burden, 
activities of daily life, disease related worry and general well-being. The scale was 
previously validated in a Swedish and Norwegian population (Hjortswang et al., 2006) 
and later in an English IBD population, with test-retest reliabilities revealing correlations 
from 0.70-0.89  (Mcdermott et al., 2013).  
Illness Cognitions Questionnaire 
The ICQ comprises the subscales, helplessness, acceptance, and perceived 
benefits. The 6-item acceptance subscale was used in this study which assesses 
acceptance of one’s CI and uses a 1-4 Likert scale from 1 “not at all” to 4 “completely” 
(scoring 6-24). The acceptance subscale has demonstrated good internal consistency (α 
= 0.91, Evers et al., 2001) and α= .92, .89 at two time points (Sirois & Hirsh, 2017). 
Coping Efficacy Scale (CES, Gignac et al., 2000).  
The 3-item CES assesses the extent that individuals feel that they 
are coping effectively with symptoms, emotional aspects and daily challenges of their 





condition measured on a Likert scale from 1 “strongly disagree” to 5 “strongly agree”. 
As in previous research (Sirois & Hirsch., 2017) ‘IBD’ replaced the term ‘illness’. The 
scale was created in error for this study and thus was scored on a 7-point Likert scale with 
the additional scale items “somewhat-disagree” and “strongly-agree” (scoring 1-21). The 
CES has demonstrated good internal consistency in arthritis (α = .80; Sirois & Hirsch, 
2013), and IBD sample (α = .90) (Sirois & Hirsch, 2017).   
Duke-UNC Functional Social Support Questionnaire (FSSQ, Broadhead et al., 1988).  
The 8-item FSSQ measured perceived social support, covering receipt of 
emotional and practical support, on a 5-point Likert scale ranging from 1 “much less than 
I would like” to 5 “as much as I would like”.  The measure is scored by averaging all 
items, resulting in scores ranging from 1-5. It has demonstrated good internal consistency 
at two time points (alphas= .91 and .93) (Sirois & Hirsch, 2017). 
Control Beliefs Inventory (CBI, Sirois, 2002).  
The 26-item CBI measures four specific health related control beliefs: General 
control, chance control, symptom control and mastery/health self-efficacy. The CBI was 
designed for use with CI populations and each subscale has demonstrated acceptable or 
good internal consistency (α= 0.70-0.91, Sirois, 2003). The original scale assessed items 
on a 6-point Likert scale, from 1 “strongly disagree” to 6, “strongly agree”. The scale 
was created in error for this study and thus was scored on a 1-7 Likert scale with 
“neither agree nor disagree” (scoring 7-182).  
The Intolerance of Uncertainty Scale-Short Form (IU-SF, Carleton et al., 2007).  
The 12-item IU-SF assesses prospective anxiety and inhibitory anxiety through 
assessing reactions to uncertainty, ambiguous situations, and the future. It demonstrated 





excellent internal consistency ( =.91) in a sample of American undergraduate students 
(Carleton et al., 2010), large community sample ( =.92) (Carleton et al., 2010, cited in 
Hale et al., 2016) and demonstrated good reliability and validity in a general population 
Chinese sample ( =.0.86).  
The Short Grit Scale (SGS, Duckworth & Quinn, 2009).  
The 8-item SGS measures trait-level perseverance and passion for long-term 
goals. It includes elements of diligence, enduring, being hard-working and not 
discouraged by setbacks, assessed on a 5-point Likert scale, 1 “not like me at all” to 5, 
“very much like me”. The measure is scored by averaging all items, resulting in a grit 
score ranging from 1 to 5. The SGS has demonstrated good internal reliability, test-retest 
reliability, and criterion reliability in studies of adolescents and young adults (Duckworth 
& Quinn, 2009; Sharkey et al., 2017). In Traino et al’s. (2019) study on college students 
with CI’s the reliability was good (α = 0.81).  
Sample characteristics 
Eighty-five participants completed the survey. Most of the participants were 
female, in remission and UK based (see Table 3). A priori power analysis determined 
the sample size needed to prevent type II errors when conducting regressions analyses. 
Applying a cautious assumption that all nine predictor variables correlated with 
resilience, a sample size of 135 was required to achieve 0.80 power at a p-value of 0.05 
(Field, 2009). A post-hoc analysis based on the six variables that significantly correlated 
with resilience and entered into the hierarchical regression analysis was conducted. The 
rule of thumb that between 10-15 participants per predictor were needed to achieve 0.80 
power at the 0.05 level was used (Field, 2009), hence, 60-90 participants were required. 






Data analytic plan 
Statistical Package for Social Sciences (SPSS) version 23 was used to analyse 
the data. Correlation analyses enabled examination of the associations between the 
continuous variables and the outcome. Categorical variables were examined via 
comparison of mean resilience scores and independent t-tests. A hierarchical regression 
analysis examined the amount of variance in resilience that could be explained by 
illness-acceptance, coping-efficacy, social support, control-beliefs, and intolerance of 
uncertainty (Field, 2009). Disease activity was entered into block 1 as a covariate; at 
block 2 illness-acceptance, coping-efficacy and social support were grouped together as 
coping resources. At block 3, control-beliefs and intolerance of uncertainty were 
grouped together as beliefs related to controllability.  
The data were examined to check for assumptions of multivariate analyses 
which involved examination of missing data, outliers, and parametric assumptions of 
normality (Tabachnik, & Fidell, 2014). Histograms, Q-Q plots, skewness, and kurtosis 
values were assessed and checked against values demonstrating normal distribution (see 
Appendix K, Stevens, 2002). The Shapiro-Wilks test (Shapiro & Wilk, 1965) was used 
because it has more power to detect differences than alternate tests (Field, 2009). 
Pearson correlation and Spearman’s rho coefficients were interpreted for normally 
distributed and non-normally distributed data, respectively. No outliers were identified 
from visual inspection of scatterplots.  Finally, the absence of multicollinearity was 
assumed because the correlation coefficients for all independent variables were not too 
highly correlated (r < .90) (Field, 2013).  
Missing data 





There was a small amount of missing data values (n=15). A statistical test 
indicated that data were missing completely at random (Little, 1988; p = 1.00). Thus, it 
was appropriate to use case mean substitution (Hanna, & Dempster, 2012); reported in 
previous research (Downey & King, 1998; Eekhout et al., 2012; FoxWasylyshyn & El-
Masri, 2005; Raymond, 1986; Roth et al., 1999). 
Descriptive data 
Table 2 summarises participant and disease-related characteristics. The majority 
were female, UK based and considered themselves to be in remission. 
  







Participant and disease characteristics  
Participant characteristics  
Gender  % (n) (female) 
Age (mean, SD) 
Country: 
United Kingdom   % (n)  
Europe   % (n) 
Canada % (n) 
 USA % (n) 
Australia % (n) 











Age of diagnosis (mean, SD) 
Illness duration (mean, SD) 
Diagnostic subtype: 
Crohn’s disease % (n) 
Ulcerative Colitis % (n) 
Other: % (n) 
Disease activity status: 
Relapse (n, %) 










Note. SD = standard deviation 
 






Descriptive scoring data from all measures are presented in Table 3. None of the 
scales had categorical cut-offs, but for all, greater scores indicated a greater presence of 
each construct.  
Table 3  
Cronbach’s alphas, and descriptive statistics for all measures 









 ------- 0 45 12.96 11.02 
Disease 
activity 
.84 0-400 38 400 201.4 90.87 
Social 
support 
.88 1-5 1.38 5.00 3.87 0.88 
Acceptance .89 6-24 6 24 16.41 4.18 
Grit .78 1-5 1.25 3 2.24 0.37 
Control 
beliefs 
.87 26-182 65 153 116.60 18.71 
Coping-
efficacy 




.89 12-60 15 60 32.47 9.3 
Resilience  .93 0-100 29 96 66.07 15.30 










Independent t-tests assessed differences between categorical variables and 
resilience. There was no significant effect for gender, t(83) = -0.11, p = 0.917, despite 
females (M = 66.2, SD = 15.2) scoring greater than males (M = 65.8, SD = 15.9). There 
was no significant effect for disease activity status (relapse/remission), t(83) = -1.8, p = 
0.917, despite those reporting to be in remission scoring greater (M = 68.3, SD = 14.6) 
than those in relapse (M = 62.1, SD = 15.9). There was no significant effect for disease 
subtype, t(78) = 0.84, p = 0.622, despite those with CD reporting greater resilience 
scores (M = 67.6, SD = 14.9) than those with UC (M = 64.7, SD =16.3). The “other” 
subtype was omitted from this analysis due to the small number in this subgroup (N = 
4). Finally, correlational analysis revealed that age and resilience were not significantly 
correlated, r(-0.54), p = 0.63.  
Correlational analyses  
All variables except grit and TSD were significantly correlated with resilience 
(p<0.001). Therefore, grit and TSD were not entered into the hierarchical regression 
analysis. As expected, negative correlations were found between disease activity and 
IOU and resilience (see Table 4).  
  






Bivariate analyses of the relationship between independent variables and resilience.  








IOU Grit Resilience 
TSD 1 -.123 .323** .188 .181 -.021 .030 .101 .197 
Disease activity  1 -.518** -.558** -.285** -.390** .429** .123 -.391** 
Acceptance   1 .736** .400** .492** -.330** -.234* .705** 
Coping-efficacy    1 .408** .348** -.400** -.082 .625** 
Social support     1 .028 -.204 .111 .456** 
Control beliefs      1 -.221* -.270* .494** 
IOU       1 .028 -.474** 
Grit        1 -.176 
Resilience         1 
       Note. TSD=Time since diagnosis. Greater scores on all scales equate to higher amount of that construct. Pearson Product-moment correlations coefficients 
are presented for disease activity, acceptance, control-beliefs, IOU, grit and resilience. Spearman’s Rho correlation coefficients are presented for TSD, social-support 









Regression analyses   
A hierarchical regression analysis was conducted to analyse the data. The model 
explained 67.1% of the variance and disease activity, social-support, coping-efficacy, 
illness-acceptance, IOU and control-beliefs were significant predictors, R2 = .671, R2 
adjusted = .646, F(2,78)=12.874, p<0.001. Table 5 reports the regression analysis. In step 
1, disease activity explained 15.7% of the variance in resilience, R2=.157, R2Adjusted = 
.147, F (1, 83) = 15.434, p = < .001. The addition of illness-acceptance, coping-efficacy 
and social support explained a further 40.6% of the variance in resilience, ∆R2 = .563, 
R2Adjusted = .541, F (3, 80) = 24.783, p < .001, with only social support and illness 
acceptance making a significant contribution to the model. The addition of control-
beliefs and IOU at step 3 explained a further 10.8% of the variance in resilience, ∆R2 = 
0.671, R2Adjusted = .646, F (2, 78) = 12.874, p < .001, making a significant contribution to 










Summary of regression analyses predicting resilience  




95.0%  Confidence 
interval for β 




1 Disease activity -.067 .017 -.396*** -.100 -.033 




























































Note. N=85. Note. N = 85. Block 1 ∆R2 = .147***, Block 2 ∆R2 = .541***, Block 3∆R2  = .646*** 
*p < .05, **p < .01, *** p<.001 
Discussion  
This exploratory study, informed by Carver’s (1998) conceptual resilience 
framework, developed a nuanced understanding of resilience in IBD populations, by 
extending existing research exploring social support, coping-efficacy and illness-
acceptance. Grit was interpreted as a feature of resilience from the qualitative data. The 
study then conducted the first statistical examination of grit, IOU, control-beliefs, and 
resilience in an IBD population, with consideration of disease activity.  






Resilience was not differentiated according to gender, age, or disease subtype. 
The regression lends support to existing studies finding that social-support, coping-
efficacy and illness-acceptance associate with resilience in IBD populations (Sirois & 
Hirsch, 2017). Sirois and Hirsch (2017) found that coping-efficacy distinguished 
thriving from resilience cross-sectionally. In the current study coping-efficacy was less 
predictive of resilience than other factors, however the measure’s validity was affected 
and thus comparison with other studies is compromised.  
These findings are in line with the supposition that an individual’s perceived 
capability to perform an action (coping-efficacy) influences emotional well-being, 
linked to agency to exert control over events (Bandura, 1977, 1997). The modified 
social learning theory (Wallston, 1992) argues that coping behaviour is contingent on 
one’s perceptions of control over health outcomes. These findings indicate resilience is 
one such outcome. Confirming the association between control-beliefs and positive 
outcomes in other CI populations (Lenze et al., 2008; Panagiotou et al., 2014), control-
beliefs predicted resilience in those with IBD.  
Uncertainty is linked to how in control one feels (McCormick, 2002). IOU was 
negatively correlated with resilience; an anticipated finding because it is predictive of 
psychopathology in CI and emotional disorder populations (Gentes & Ruscio, 2011; 
Kurita et al., 2013; Mcevoy & Maloney, 2012). Combined, IOU and control-beliefs 
contributed 10.7 % of the variance in resilience over and above other factors. In this 
study, IOU also held negative correlations with control-beliefs, coping-efficacy and 
illness-acceptance. Hence these positive appraisals (which predict resilience) may 





indirectly influence the association between IOU and resilience. However, future 
research could investigate how these cognitions mediate the IOU/resilience association. 
Grit, the perseverance towards long-term goals (Duckworth et al., 2007) was 
found not to significantly correlate with resilience. This was unanticipated given 
previous findings on grit’s positive correlation with HRQOL, psychological wellbeing 
and life satisfaction (Duckworth et al., 2007; Sharkey et al., 2017; Singh & Jha, 2008; 
Vainio & Daukantaite, 2016). It might be that what participants voiced in this study was 
a daily form of endurance, persisting diligently when presented with difficulty (Hamby 
et al., 2013), supported by Carver (2010) who argued the struggle to prevail is a likely 
associate of resilience. This study suggests that in those with IBD, if one is unable to 
envisage long-term goals due to limitations imposed by unpredictable disease activity, 
the character trait of persistence; the tendency to continue striving on a daily basis, may 
be more apt and has been found to correlate with resilience in a non-clinical sample 
(Kim et al, 2013). Research examining endurance and resilience in relation to IBD is 
warranted. Furthermore, those with IBD worry about their education or occupation 
being affected (Luo et al., 2019). Hence the negative correlation between grit and 
resilience generated in this study suggests that grit triggers the threat system (LeDoux, 
1998) within a sociocultural context whereby value is placed on productivity and 
occupational success. Acceptance of illness-related limitations may therefore be more 
pertinent. 
Like previous findings with IBD populations, illness-acceptance predicted 
resilience (Kiebles et al., 2010; Sirois & Hirsch, 2017); perhaps because it positivises 
IBD’s meaning, aiding tolerance of its unpredictable, uncontrollable nature (Evers et al., 
2001). Those with greater acceptance also possessed greater coping-efficacy, so it may 





be that the implementation of effective coping strategies enables acceptance and 
resilience (Carver, 1998). It is possible that a reciprocal and mutually reinforcing 
relationship exist between these variables and resilience, however future longitudinal 
research would be needed to elucidate causal pathways. Finally, the positive correlation 
between social support and illness-acceptance mirrors previous findings (Janowski et 
al., 2012). The qualitative analysis indicated complexities within the relationship 
between social support and resilience, thus while it was found to predict resilience, the 
FSSQ (Broadhead et al, 1988) did not capture these complexities, limiting the findings. 
Resilience and disease variables 
Disease-activity negatively predicted resilience explaining 15.7% of the variance 
in the model (prior to controlling for the other variables). This was unsurprising because 
higher disease-activity associates with distress (Graff et al., 2006) depression and 
anxiety (Tribbick et al., 2017) and lower QOL (Vander-Have, 2014). (Dorrian et al., 
2009; Knowles et al., 2011; Knowles et al., 2013; Zhang et al., 2016). These findings 
suggested that once social support, acceptance, and coping-efficacy were controlled for, 
combined, they reduced the negative effect on resilience of disease activity, turning it 
into a small positive effect. This indicates interrelationships between the variables and 
disease activity and that their effects are not in isolation.  
Prior research has elucidated that disease-activity can directly impact 
perceptions of one’s illness influencing a negative mindset and that they mediate the 
association between disease-activity and negative outcomes (Tribbick et al., 2017). The 
negative appraisals in these existing studies pertain to chronicity and lack of 
controllability. The findings in this study indicate a complex relationship between 
disease activity, the variables under examination in this study and resilience. Thus, 





further research could extend these findings by conducting moderator or mediator 
analyses to diversify the types of illness perceptions under examination and further 
elucidate the role of disease activity and these variables in relation to resilience.  
 Acceptance was positively and significantly correlated with TSD. This suggests 
acceptance may evolve with experience, perhaps because a process of desensitisation to 
aversive IBD experiences occurs over time (Carver, 2010). Resilience is a dynamic 
process (Skrastins & Fletcher, 2016; Werner, 1994) and longitudinal research that 
collects data from the point of diagnosis over the disease course would further 
understanding of the temporal relations between variables and resilience. 
Study limitations 
The study limitations should be acknowledged when interpreting the findings. 
Phase A yielded a small sample size (Braun & Clarke, 2013; Fugard & Potts, 2014). 
However, the data were deemed adequate to meet the study aims. Selection bias may 
have influenced who volunteered (Khazaal et al., 2014) towards those perceiving 
themselves as resilient. The sample was a homogenous population of white, British, 
educated females in remission. Thus, findings are less transferable to others, particularly 
those experiencing active disease. Reflective diary keeping would have aided reflection 
on the researcher’s contributions to the interpretation of data (Ortlipp, 2008).  
Due to the cross-sectional design, causal inferences could not be determined 
(Sedgwick, 2014). Furthermore, the design did not enable exploration of the influence 
of confounding factors including personality traits or emotional disorders which may 
impact on resilience (Kim et al., 2013). Additionally, self-report measures bear the risk 
of recall bias and shared method variance; meaning the results could have been 
artificially inflated (Podsakoff et al., 2003). The measures used were psychometrically 





sound, however the Likert scales for the CES and CBI were entered erroneously, thus 
findings for those measures should be interpreted with caution.  Finally, the study relied 
upon self-reported diagnoses and disease-activity. While recruitment from clinical 
settings may have improved the accuracy of this data, arguably, capturing perceived 
disease severity holds more value and self-reports are comparable to medical reports 
(Randell et al., 2014). 
The complexities of defining resilience are widely recognised (Windle, 2010). 
Within this study, resilience was measured as resilience-related traits (Connor & 
Davidson, 2010) and as a dependent variable which is fluid in nature but was captured 
cross-sectionally.  While this research was exploratory and aimed to develop a better 
conceptual understanding of resilience in those with IBD, these conceptual, 
measurement and design issues, mean that caution should be applied when interpreting 
the findings and when comparing these findings with other studies.  
The current sample were only partially representative of the general population. 
Those known to have the highest diagnostic incidence fall within the age-bracket of 20-
29 years (Johnston & Logan, 2008) and in this study the mean diagnostic age was 26.53 
years. However, approximately three quarters were female and epidemiological studies 
suggest there is a 1:3 incidence ratio of males to females (Bernstein et al., 2006; Brant 
& Nguyen, 2008, GDB collaborators 2019).  
Nevertheless, the post-hoc analysis indicated that the sample size was adequate 
to avoid type I or II errors. The bivariate correlations between variables and resilience 
were at the .01 alpha level which reduces the risk of type 1 errors. Finally, this 
exploratory research adds to a burgeoning body of literature on resilience in IBD 
populations. 





Implications for clinical practice  
These findings indicate that across the illness trajectory fostering one’s ILOC, 
coping-efficacy and illness-acceptance may improve resilience. In line with current 
guidance (NICE, 2010), CBT enables practitioners to foster these psychological 
resources and challenge negative appraisals. However, acceptance is more specifically 
addressed through the application of third-wave therapies, such as Mindfulness-Based 
Stress Reduction (Kabat-Zinn, 1990), Compassion Focused Therapy (Gilbert, 2009) or 
Acceptance and Commitment Therapy (ACT, Hayes, 2004), which aim to enable one’s 
ability to embrace the present moment and difficult emotions (Khoury et al., 2013). A 
review of ACT revealed promising findings for those with long-term conditions 
(Graham et al., 2016). Additionally, targeting IOU as a transdiagnostic factor in line 
with CBT for Generalised Anxiety Disorder (NICE, 2011) might foster resilience. 
Future research could examine the effectiveness of third-wave therapies for those with 
IBD.  
Fostering the aforementioned factors may be particularly important when 
disease-activity is high. Higher disease activity also leads to a lower perception of social 
support; thus, practitioners should encourage engagement with health-care services at 
these times. It may be that professional support is creatively adapted such as utilising 
phone or video contacts so that it is accessible to individuals where disease activity 










The current study found that illness cognitions pertaining to coping resources 
and beliefs about controllability predict resilience over and above the negative 
predictive influence of disease activity. Rather than perseverance to long-term goals, 
daily persistence or endurance might be more important to resilience in an IBD 
population. Future research should examine endurance, causal pathways between illness 
cognitions and resilience, and the mediating influences of these illness cognitions 
between disease activity and resilience. Finally, research could examine the application 
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Participant survey comments 
*Participants were asked to consider practical aspects of the preliminary online survey 
(e.g. length of survey and ease of completion) and to identify if any potential emotional 
issues might arise.  
It took them approximately 15 minutes to complete the survey 
The feedback was largely positive about the length and utility of the survey; however, 
they gave their views on the order of the measures within the survey. 
The length felt “okay” but advised to consider order of scales so that it alternates short 
and long scales to keep effort up and willingness to complete until the end; 
Some items felt repetitive. 
The layout is important, to have the Likert scale visible where each item is; 
Comments regarding the wording of the resilience scale (this was because the preliminary 
scale contained the version of the CD-RISC that was online prior to purchasing). Once 
purchased the full accurate wording of the scale was amended. 
  





























Information sheets (focus group and interviews) 
 
Information sheet 
An exploration of factors associated with resilience in those with IBD: A focus 
group 
 
Department of Psychology. 
Clinical Psychology Unit 
Doctor of Clinical Psychology (DClin Psy) 
programme 
 
Telephone: 0114 222 6574 
Email: kboden@sheffield.ac.uk 
You are invited…. 
To participate in a research study conducted at the University of Sheffield. Before you decide to 
take part it is important that you understand the research that is being done and what it will 
involve, so that you can give informed consent. Please take the time to read the following 
information carefully and discuss it with others if you wish. You are welcome to ask any questions 
to Katie Boden (lead researcher) if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 





 June 2019. The focus group will last approximately 1 hour to 1 and a half hours 
and a specific time will be agreed when enough participants have expressed an interest.  
The project and aims 
The overall aim of the research is to explore the factors that influence resilience in individuals 
with IBD. The first element (which you are being invited to participate in) is a group interview to 
discuss what factors are felt to be important in influencing resilience from those with lived 
experience of IBD. This will contribute to the development of the research question and second 
part of the study. 
Why have I been invited to participate in the study? 
You have been invited to participate because you have been given a medical diagnosis of IBD 
(either Crohn’s Disease or Ulcerative Colitis). Approximately seven other people will also be 
recruited to take part in the group interview for this study. 





Do I have to take part? 
It is up to you to decide whether or not you would like to take part and you are under no obligation 
to participate. If you decide to take part you will be given this information sheet to read and keep 
and you can withdraw from the study at any time during the focus group and up until 4 weeks 
after. You do not need to give a reason. 
What will happen once I agree to participate in the study? 
You will be asked to attend a group interview at a time that is convenient. You will be asked 
questions about what you think the important factors are that influence resilience in living with 
IBD. This will take approximately 60 minutes and it is your choice whether you feel comfortable 
answering any of the questions. The group interview will be audio-recorded and the files 
transferred to a password protected computer that is secure and regularly backed up. Data will be 
destroyed on successful publication of the research. 
Will my taking part in this project be kept confidential? 
All the information that we collect about you during the course of the research will be kept strictly 
confidential and will only be accessible to members of the research team. An alternative name (a 
pseudonym) will be assigned to you on completion of the group interview (you can choose this 
yourself if you wish) and so you will not be identifiable in any reports or publications.  
What are the benefits of taking part? 
Whilst there are no immediate benefits to participating in the project, it is hoped that this work 
will add to our knowledge base around the factors that influence resilience so that it can inform 
the help individuals receive around managing their condition. It is also hoped that it will stimulate 
further research in this area. 
What are the possible disadvantages and risks of taking part? 
Some of the questions will likely prompt thought around how you have managed your condition, 
which may make you feel uncomfortable in some way. If you feel distressed at any stage, you can 
leave the interview or withdraw from the project completely. 
What if something goes wrong or if I become distressed as a result of taking part in the 
study? 
If after participating, you decide that you would like to withdraw your data from the study please 
email kboden@sheffield.ac.uk, quoting the pseudonym allocated to you at the end of the study.  
You do not need to provide a reason for withdrawing from the study.  
If you feel distressed after participating, you can contact your GP or a non-statutory organisation 
such as Crohn’s and Colitis UK. 
If, after participating in the study, you wish to raise a complaint, you can do this by contacting Dr 
Glenn Waller (Head of Psychology Department) on 0114 222 6571 or by email on 
g.waller@sheffield.ac.uk.  
What type of information will be sought from me and why is the collection of this 
information relevant for achieving the research project’s objectives? 
Information about your age, gender, ethnicity and your diagnosis or IBD will be collated because 
this will help the researcher see whether these factors impact on levels of resilience 





What will happen to the results of the research project? 
The study results will be written up and submitted as a doctoral thesis. You will not be identifiable 
in any report or publication of these results. The results of this study may be published in a peer-
reviewed scientific journal in the future. 
Will I receive any reimbursement of expenses for taking part in this research? 
You will receive reimbursement on any travel costs you have incurred so please keep any 
receipts for public transport travel. You will also be given a £10 gift voucher as a gesture of 
thanks for your participation. 
Who is organising and funding the research? 
The University of Sheffield is organising and funding this research 
Who has ethically reviewed the project? 
The ethics of this research has been reviewed and approved by The University of Sheffield’s 
Research Ethics Committee. 
Who is the data controller? 
The University of Sheffield will act as the Data Controller for this study. This means that the 
University is responsible for looking after your information and using it properly. 
What is the legal basis for processing my personal data? 
According to data protection legislation, we are required to inform you that the legal basis we are 
applying in order to process your personal data is that ‘processing is necessary for the 
performance of a task carried out in the public interest’ (Article 6(1)(e)). Further information can 
be found in the University’s Privacy Notice  
https://www.sheffield.ac.uk/govern/data-protection/privacy/general 
Contact for further information 
If you would like any further information you can contact Katie Boden (lead researcher) by 
email kboden1@Sheffield.ac.uk 
 
Thank-you for taking part in the project. 
  







An exploration of factors associated with resilience in those with IBD: An 
interview 
 
Department of Psychology. 
Clinical Psychology Unit 
Doctor of Clinical Psychology (DClin Psy) 
programme 
 
Telephone: 0114 222 6574 
Email: kboden1@sheffield.ac.uk 
You are invited…. 
To participate in a research study conducted at the University of Sheffield. Before you decide to 
take part it is important that you understand the research that is being done and what it will 
involve, so that you can give informed consent. Please take the time to read the following 
information carefully and discuss it with others if you wish. You are welcome to ask any questions 
to Katie Boden (lead researcher) if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
*The date and time of the interview will be negotiated between you and the researcher. This can 
take place face to face or via telephone or skype. It is intended to last approximately 1 hour.  
The project and aims 
The overall aim of the research is to explore the factors that influence resilience in individuals 
with IBD. The first element (which you are being invited to participate in) is an interview to 
discuss what factors are felt to be important in influencing resilience from those with lived 
experience of IBD. This will contribute to the development of the research question and second 
part of the study. 
Why have I been invited to participate in the study? 
You have been invited to participate because you have been given a medical diagnosis of IBD 
(either Crohn’s Disease or Ulcerative Colitis).  
Do I have to take part? 
It is up to you to decide whether or not you would like to take part and you are under no obligation 
to participate. If you decide to take part you will be given this information sheet to read and keep 
and you can withdraw from the study at any time during the interview and up until 4 weeks after. 
You do not need to give a reason. 
What will happen once I agree to participate in the study? 





You will be asked to attend an interview at a time that is convenient. You will be asked questions 
about what you think the important factors are that influence resilience in living with IBD. This 
will take approximately 45 to 60 minutes and it is your choice whether you feel comfortable 
answering any of the questions. The interview will be audio-recorded and the files transferred to 
a password protected computer that is secure and regularly backed up. Data will be destroyed on 
successful publication of the research. 
Will my taking part in this project be kept confidential? 
All the information that we collect about you during the course of the research will be kept strictly 
confidential and will only be accessible to members of the research team. An alternative name (a 
pseudonym) will be assigned to you on completion of the interview (you can choose this yourself 
if you wish) and so you will not be identifiable in any reports or publications.  
What are the benefits of taking part? 
Whilst there are no immediate benefits to participating in the project, it is hoped that this work 
will add to our knowledge base around the factors that influence resilience so that it can inform 
the help individuals receive around managing their condition. It is also hoped that it will stimulate 
further research in this area. 
What are the possible disadvantages and risks of taking part? 
Some of the questions will likely prompt thought around how you have managed your condition, 
which may make you feel uncomfortable in some way. If you feel distressed at any stage, you can 
terminate the interview or withdraw from the project completely. 
What if something goes wrong or if I become distressed as a result of taking part in the 
study? 
If after participating, you decide that you would like to withdraw your data from the study please 
email kboden1@sheffield.ac.uk, quoting the pseudonym allocated to you at the end of the study.  
You do not need to provide a reason for withdrawing from the study.  
If you feel distressed after participating, you can contact your GP or a non-statutory organisation 
such as Crohn’s and Colitis UK. 
If, after participating in the study, you wish to raise a complaint, you can do this by contacting Dr 
Glenn Waller (Head of Psychology Department) on 0114 222 6571 or by email on 
g.waller@sheffield.ac.uk.  
What type of information will be sought from me and why is the collection of this 
information relevant for achieving the research project’s objectives? 
Information about your age, gender, ethnicity and your diagnosis or IBD will be collated because 
this will help the researcher see whether these factors impact on levels of resilience 
What will happen to the results of the research project? 
The study results will be written up and submitted as a doctoral thesis. You will not be identifiable 
in any report or publication of these results. The results of this study may be published in a peer-
reviewed scientific journal in the future. 
Will I receive any reimbursement of expenses for taking part in this research? 





You will receive reimbursement on any travel costs you have incurred (if relevant) so please 
keep any receipts for public transport travel. You will also be given a £10 gift voucher as a 
gesture of thanks for your participation. 
Who is organising and funding the research? 
The University of Sheffield is organising and funding this research. 
Who has ethically reviewed the project? 
The ethics of this research has been reviewed and approved by The University of Sheffield’s 
Research Ethics Committee. 
Who is the data controller? 
The University of Sheffield will act as the Data Controller for this study. This means that the 
University is responsible for looking after your information and using it properly. 
What is the legal basis for processing my personal data? 
According to data protection legislation, we are required to inform you that the legal basis we are 
applying in order to process your personal data is that ‘processing is necessary for the 
performance of a task carried out in the public interest’ (Article 6(1)(e)). Further information can 
be found in the University’s Privacy Notice  
https://www.sheffield.ac.uk/govern/data-protection/privacy/general 
Contact for further information 
If you would like any further information you can contact Katie Boden (lead researcher) by 
email kboden1@Sheffield.ac.uk 
 













Consent form (focus group) 
 
Consent Form  
Exploring resilience factors in individuals with Inflammatory Bowel Disease  
 
Please tick the appropriate boxes Yes No 
Taking Part in the Project   
I have read and understood the project information sheet or the project has been fully explained to me.  
(If you will answer No to this question please do not proceed with this consent form until you are fully 
aware of what your participation in the project will mean.) 
  
I have been given the opportunity to ask questions about the project.    
I agree to take part in the project.  I understand that taking part in the project will include participating in 
a focus-group/interview and that this will be audio-recorded. I understand that audio data will be 
destroyed once the research has been successfully published. 
  
I understand that my taking part is voluntary and that I can withdraw from the study up until 4 weeks after 
the focus group. I do not have to give any reasons for why I no longer want to take part and there will be 
no adverse consequences if I choose to withdraw. I understand that if I do not wish to answer any 
particular questions, I am free to decline.   I am aware I can contact the researcher Katie Boden on 
kboden1@sheffield.ac.uk to discuss this further if I wish. 
  
How my information will be used during and after the project   
I understand my personal details such as name, phone number, address and email address etc. will not be 
revealed to people outside the project. 
  
I understand and agree that my words may be quoted in publications, reports, web pages, and other 
research outputs. I understand that I will not be named in these outputs unless I specifically request this. 
  
I understand and agree that other authorised researchers will have access to this data only if they agree 
to preserve the confidentiality of the information as requested in this form.  
  
I understand and agree that other authorised researchers may use my data in publications, reports, web 
pages, and other research outputs, only if they agree to preserve the confidentiality of the information as 
requested in this form. 
  
I give permission for the focus-group data that I provide to be given to the Research Support Officer at 
the Clinical Psychology Unit University of Sheffield so it can be used for future research and learning.  
  
So that the information you provide can be used legally by the researchers   
I agree to assign the copyright I hold in any materials generated as part of this project to The University of 
Sheffield. 
  
   
Name of participant  [printed] Signature Date 





















Interview schedule used for focus group and individual interviews 
Core question Prompts 
Ask everyone’s name (focus group),  
how long you have lived with IBD for 
and (if comfortable to answer) which 
subtype it is? 
 
N/A 
Do you feel this definition of resilience 
is relevant to your experience of your 
condition? 
 
Definition given to participants “resilience 
as the ability to bounce back from 
adversity or challenges” 
Clarify many definitions of resilience but 
for the purpose of the research this one has 
been chosen. Clarify definition if required 
Are there any disease-specific factors 
that you think have influenced your 
resilience? 
Prompts: Does anything come to mind? 
e.g. Has the time since diagnosis 
influenced resilience? 
Has disease subtype (CD, UC) influenced 
resilience? 
Has the level of disease-activity influenced 
resilience? 
Are there any psychological factors  that 
you feel have affected your resilience 
levels? 
 
Prompts: Explain psychological processes 
include what is in your mind and may 
include coping strategies. Does anything 
come to mind? 
Do thought processes influence or relate to 
your resilience? 
Do your beliefs influence or relate to your 
resilience? 
Do your feelings influence or relate to 
your resilience? 





Do your views on your condition influence 
or relate to your resilience? 
 
Core question Prompts 
What areas of your life do you feel your 
condition has impacted on? 
 
Prompts: Does anything come to mind? 
Does it impact on your employment? 
Does it impact on your intimate 
relationships? 
Does it impact on your social life? 
Do you feel as though your ability to be 
resilient has changed since you started 
experiencing IBD symptoms? 
 
Prompt: How might coping with 
challenges have changed before or after 
your IBD diagnosis? 
How have your coping styles or resilience 
changed over course of the condition? 
What are your views on the important 
factors that enable you to manage your 
condition? 
 
Prompt: Are there obstacles to managing 
your condition? 
Do you think if those factors were taken 
away it would affect your ability to be 
resilient? 
Have there been times during your 
condition that you have felt more 
resilient than others? 
Prompt: Can you recall a time when your 
felt your resilience was low? Can you 
recall a time when you felt your resilience 
was high? 
What are your main sources of support? 
 
Prompt: Is this support the most important 











Braun and Clarke (2006) thematic analysis steps  
 
1. Familiarisation of data. 
The main researcher undertook the role of interviewer, transcriber and data-
analyst which facilitated immersion in the data and familiarisation. The transcript was 
checked against the recordings for accuracy. Time was taken to repeatedly read the 
transcripts and elements of the data that were deemed meaningful were highlighted. 
2. Generating initial codes 
Line-by-line coding was conducted by electronic notetaking (see line by line 
coding example below). The researcher was mindful of the surrounding text so that 
context was not lost. Braun and Clarke (2006) recommend coding multiple times in order 
to uncover potential multiple meanings, thus the transcripts and codes were read 
repeatedly, and additional notes made that were based on semantic meaning. The research 
question and aims were kept in mind throughout. Attention was paid to word choices, 
repetitions, how experiences were described and use of metaphor. The data-analyst was 
mindful to give equal attention to each line. Further, all relevant extracts for each theme 
were collated and either utilised as illustrative quotes in the final report or as part of a 
separate document (see Appendix G). Some codes considered less relevant to the research 











Line-by-line coding examples: 
Data extracts from transcripts Coding (descriptive and 
semantic) 
Sally: Other things that happen in life, if you can get through how bad 
having IBD is that actually you can cope with a lot more and I think it 
becomes a bit of a reference that you might say, I’m in real pain, oh but 
it’s not as bad as the pain I might feel, if I had a flare up 
Comparing IBD challenges to 
other adverse events 
desensitisation 
Harriet: yeh I agree with that totally and on my shorter term scale when 
you are having the flare ups, erm, kind of, I’ve got to a point now where 
I can’t stop this kind of letting me do everything that I still want to do, 
if I’m having a flare up its not going to stop me from going out there, 
doing my socialising, having loads of plans that I’ve already made, so 
it’s kind of learning how to kind of function around the IBD diagnosis 
and erm still, kind of, because when I was diagnosed I was only 15 and 
my friends wouldn’t have really understood, like what was going on, 
erm , so it was kind of like learning to just carry on and staying as I was 
at that age to like, maintain like, my social life 
Sharing experience with peer, 
Making note of disease activity 
and effects of time on mindset 
Determination to function as 
well as desires 
Meeting goals, enduring despite 
symptoms, perseverance- grit 
Social goals important - grit 
Adaptation to maintain 
functioning 
Age, young friends not 
understanding-invisible struggle 
Act normal, brave face to stay 
connected to friends-stoicism 
Researcher: that sounds quite lonely   
Harriet: yeh its hard, yeh, yeh I just didn’t really, well it’s not something 
I’d ever like come across, erm  
 
Emotionally demanding to keep 
functioning despite IBD 
challenges and others not 
understanding 
New experience for her 
Sally: cos you were very young, that’s a.. 
Harriet: yeh, teenage years, I say luckily, that’s probably the wrong 
word, but my brother had it or was diagnosed it’s a couple of year 
before so me and the family sort of understood it so it wasn’t as lonely 
as it could have been but more in terms of my friends being at school 
and my social life it was kind of trying to maintain where I was at in 
that part of my life whilst still having the diagnosis, er, yeh 
Suggestion of age as an 
influencing factor 
Family/other with lived 
experience understanding 
helping combat aloneness, aiding 
resilience 
Brave face, endure symptoms to 
maintain social identity 
Concealing illness 





Researcher: Yeh, and it sounds like for you (looking at Sally) if I can deal 
with that then I can deal with other stuff that comes along, like it sounds 
like a really positive mind frame to have 
Sally: yeh I think it’s really easy to have a positive mind frame when 
you’re in remission 
Harriet: yes definitely (laughs)  
Sally: and it’s hard when you have a relapse, I think that’s the, but I mean 
I would agree in terms of you adapt your life accordingly and [pause] but 
definitely and in some ways if I’m honest it’s made me less tolerant of 
other people at times probably brought out a less tolerant side of me 
because erm [pause] because the excuses that other people might come 
up with, and you think really? actually that doesn’t register on the, erm, 





Disease activity as affecting 
resilience and mind frame 
 
In agreement regarding disease 
activity 
Adapting to functioning around 
disease activity 
Intolerance of others, 
dismissiveness of others 
struggles  
Questioning legitimacy of others 
difficulties  
Comparison of IBD challenges 
to others, disruption to 
functioning 
 
Claire: erm yeh in a way I think that people still don’t 
understand it and people don’t appreciate quite how bad it 
is so it actually I think helps your resilience cos you feel 
like you can’t show it so you almost have to go the other 
way that you’ve gotta put the brave face on for other 
people but then it becomes normal for you because you’re 
acting it, it becomes normal, erm but because people don’t 
quite understand it, or it feels, I think like with my close 
friends, good friends they get it, but you do still feel a bit 
of stigma for it, like I don’t want to be labelled as the 
person who’s poorly cos of this, how people treat you for 
it or don’t treat you for it cos you don’t let them in that 
much, it’s just like when you’re tired and people are like 
why you tired you know like just family say you shouldn’t 
be tired you’re young, it’s things like that and they don’t 
really know what they’re saying and they obviously they 
Others not understanding the struggle 
Struggle invisible 
Others diminishing the extent of the 
challenges 
Helping resilience as its invisible, a pretence 
to self and others, stoicism 
Not showing emotions, “brave face” for 
others- stoicism 
“brave face” transcending to her 
Close social circle understanding but felt 
stigma 
Fear of being labelled, identity as poorly 
person 
Fear of being different, being treated 
different 
Avoiding intimacy, dismissing others 





know what I’ve got but they just haven’t thought about 
what they’re saying to you so when someone says 
something like that to you and you’re like [pause]  
 
Others as dismissive and not understanding 
 
Dismissive comments, lack of “knowing” 
from others, insensitivity 
Researcher: yeh what’s it like hearing comments like that 
Claire: Well it’s not very nice but I don’t sort of respond 
to them cos I just think, especially with older family 
members it’s not gonna make any difference, they won’t 
get it  
 
 
Unpleasant feeling being misunderstood 
 
Choosing not to clarify and explain 
condition, withholding due to expectation 
others won’t understand 
 
 
3. Searching for themes 
The codes were reviewed for comparisons, similarities, and contrasts. Similar 
codes enabled identification of broader themes and subthemes and diagrams/maps were 
constructed to organise the themes. The conceptual maps evolved (below are three 
examples of maps constructed in chronological order). The research team also read the 
transcripts and themes/constructs that were apparent within the data were discussed in 
research supervision.  
Conceptual maps examples: 
 
 














4. Reviewing themes  
Research supervision was used to review the thematic maps and alternative 
possibilities and perspectives on the data were discussed. Diagrams and supporting quotes 





facilitated decision-making and repeatedly reading transcripts ensured that themes 
reflected the dataset as a whole and represented all participants discourse.  
5. Defining and naming themes  
Braun and Clarke (2006) recommend describing the central organising features of 
themes in a succinct and coherent manner, accompanied by quotes to illustrate themes. 
Research supervision was utilised to discuss the various constructs (and their 
accompanying definitions) that may be present in the analysis and this aided clarity over 
themes.  
6. Producing the report 
The report aimed to provide a clear, concise narrative of the themes and 
interpretation of the data, giving relatively equal attention to each theme. Braun and 











Illustrative quotes for each theme (pseudonyms used) 
Superordinate theme: Grit 
Subordinate theme: Reclaiming control through autonomous coping 
“If there’s a problem, I’m proactive and other people have sort of said that to me, like I 
admire so much how you’re dealing with it and then how I talk about it so there is a 
psychological satisfaction to be had from that knowing I’m not gonna let it beat me.” 
(Annie) 
“You adapt your life accordingly.” (Sally) 
“For me it’s about understanding myself, like I had to be very aware of what I was 
eating, what I was drinking, making sure that I understood my condition, I couldn’t 
expect other people to understand if I didn’t know what’s going on.” (Harriet) 
“Quite a positive person and I’m very erm I don’t just let things just happen to me I will 
go and sort things out.” (Annie) 
“I’d rather deal with it myself erm unless its, I’ve not felt like I really needed to go.” 
(Claire)   (referring to consideration of professional help) 
“I’ll try and eat food that’s a bit more carbs, potato based bread cos its thicker and it 
helps, its heavy and helps everything come out, stay away from veg or anything high 
fibre, I’ll stay away from things that I know are gonna bother it if it’s really inflamed in 
there.” (Claire) 





“And I think cos I feel like I handle it quite well I don’t want someone to panda to me, I 
don’t want to be pandered too.” (Claire) 
“You feel like you literally have no control, you have no control when you want to go to 
the toilet, you have no control over whether your tummy’s going to hurt today and how 
that’ll feel you literally it feels like you lost control of anything.” (Sarah) (before feeling 
in control and developing self-efficacy) 
 “I think a lot of the time it’s our reaction to stuff we have the control over how we react 
to something, we don’t have the control over what’s happening to us, we just have to 
decide how we’re going to deal with that.” (Sarah) (self-efficacy of emotions) 
“Kind of recognise what symptoms are telling you that a flare is coming and stuff so to 
me I think it’s always essential to have a plan,” (Sarah) 
Subordinate theme: Legitimacy under question, maintaining identity through self-
preservation: 
“Like straight away was really helpful cos I couldn’t believe that someone actually 
believed me straight.” (Claire) (point of diagnosis) 
“Like I’ll go on course and stuff in London and I just keep it to myself cos then you don’t 
have to explain it to anybody.” (Claire)  
“People are like why you tired you know like just family say you shouldn’t be tired you’re 
young, it’s things like that and they don’t really know what they’re saying and they 
obviously they know what I’ve got but they just haven’t thought about what they’re 
saying.” (Claire) 





“I threw the book across the room and I thought I’m going to deal with it how I want to 
deal with it.” (Annie) 
“The frustration from it being an invisible illness where erm you know that some people 
are questioning whether it’s as bad as you’re making out or erm then with us you’re 
paranoid if they might be but you’re not sure kind of thing.” (Annie) 
“You either lie to them and tell them you’re alright or you can actually tell them how 
you are and you can literally see their eyes glaze over when you’re telling them that 
you’re still sick.”  (Sarah) 
“It’s sometimes just easier not to tell people in the first place but then they’re not watching 
you and asking these questions.” (Harriet) 
“It’s like it’s not so much of a focus for myself in my own life, so it doesn’t have to be  
something you associate me with, you don’t have to look at me and ask me all these 
questions just like let that happen in the background.” (Harriet) 
“To explain the whole, whole diagnosis and what’s wrong with me, people don’t actually 
wanna know that realistically.” (Harriet) 
“Well my manager knows and people I think people I’m close with at work know but 
not everybody.” (Claire) (limited disclosure) 
Subordinate theme: Endurance (an invisible struggle) 
“Yeh helpful, just don’t even go there, I wonder at times if having IBD has made me 
more independent.” (Sally) 
“Trying to still do all the things you need to do.” (Annie)  





“I’ve got to a point now where I can’t stop this kind of letting me do everything that I still 
want to do.” (Harriet) 
“I’m going to carry on and do my thing and not let it stop me.” (Harriet) 
“It was kind of like learning to just carry on and staying as I was at that age to like, 
maintain like, my social life.” (Harriet) 
“Not letting it stop me into doing what I need to do, and for me that’s really important.” 
(Harriet) 
“If I’m having a flare up it’s not going to stop me from going out there, doing my 
socialising,  having loads of plans that I’ve already made.”(Harriet) 
 “I don’t mind now, the challenge, I kind of don’t mind challenges in my life, whatever 
the challenges are, I quite like fighting them (all laugh), I quite like seeing a challenge 
and acknowledging that challenge, how am I gonna beat that.” (Harriet) 
“I just keep pushing through, and ensure it doesn’t stop me doing my uni work and 
doesn’t stop me doing or achieve what I want to achieve” (Harriet) 
“Times when I could of shouldn’t have been there, you know times like that when I 
force myself to do things.” (Claire) 
“Sit at home and you’re not at work and you feel really guilty for not being at work like 
the guilt always kicks in and I think cos you’ve been brought up with the whole you 
work for a living.” (Claire) (social pressure to endure) 
“I think it’s just that but people just get on with things don’t they.’ (Claire) 





“I’m a bit ignorant to it, so I kind of think well I’ll put it to the back of my mind that 
I’ve got anything wrong with me because it’s just easier just to, get on with things.” 
(Claire) 
“If someone else was saying that to me then I’d feel awful for them but when I’m 
saying it, it’s just everyday life.” (Claire) 
“When the symptoms are bad it’s hard to get yourself out of a mental state of I just 
don’t wanna do anything I don’t wanna see anybody it’s that kind.” (Claire) (endurance 
hard when symptoms more severe) 
“I think just it’s doing the things you like to do that make a massive difference and even 
though sometimes going out is hard cos you’re scared to do it, it helps a hell of a lot cos 
you’re doing stuff that you enjoy.” (Claire) 
“I have a reference point when I’m ill or when anything’s happened, and I’ll say well 
actually it’s not as bad as that.” (Sally) (desensitisation - allows endurance) 
“I think your brothers got the right attitude, for me, I think he’s got the right attitude, to 
carry on regardless.” (Sally) 
“Students that I’ve had with IBD, I have to say they are not necessarily the ones who 
have asked for exceptional circumstances…...maybe that’s resilience.” (Sally) 
 “There was never a question that you wouldn’t get up and go to school or work or 
anything like that so that carries on that stays with you throughout your life.” (Sally) 
 “Trying to still do all the things you need to do.” (Annie) 
“You either don’t do life or you deal with life on or own terms and take that control 
back and I think that’s when the resilience comes in.” (Sarah) 





Superordinate theme: Social support 
Subordinate theme: Supportive, understanding others 
“Even my friends who understand a lot about it now, but sometimes they’re too nice, 
like if I’m having a flare up like they wrap me up in cotton wool, which I find a bit 
patronising like I always when I’m ill I hate people treating me like I’m ill whereas my 
parents like I’ve mentioned before are very much tough love.” (Harriet) 
“I think it’s just easier when people understand what you’re going through cos you 
don’t have to explain everything, it’s like an unsaid communication between the two of 
you, you don’t have to say it it’s difficult to put into words how IBD can make you feel 
sometimes.” (Harriet) 
“Well works has been amasing I have to say my boss I told him straight away and erm 
he said have as much time off as is needed.” (Annie) 
“Just having emotional support and having someone to talk to, knowing those nurses are 
at the end of the line.” (Annie) 
“The sheer number of women who came to me and emailed me or sent me a card saying 
its amasing how you’re dealing with this.” (Annie) 
“Yeh sort of friends and family my mum always asks me how I am and she’ll’ send little 
cards and presents through the post and obviously my husband has been great but I’d have 
to say work really cos they’ve just been utterly supportive.” (Annie) 
“They were just as flexible as I needed them to be.” (Annie) (about employers) 





“I feel like I need to support people as well because it gives my entire journey of crapness 
a purpose if I use it positive ways and me being able to offer people advice or support 
makes me feel better.” (Sarah) 
 “I mean it was nice to be able to talk to people who understood anyway so that was 
helpful.” (Sarah) 
“My MD actually had Crohn’s disease which helped monumentally.” (Sarah) 
“He’s [husband] probably the only person he actually kind of gets it and he’s very patient 
with it, to be fair my mum and dad are aswell, my family my close family are and friends.” 
(Claire) 
 “Like if I’m on a night out and I don’t feel good and I’ll say to a friend I’m gonna have 
to go home now and they understand it and things like that I think it must just be the 
people that you are around.” (Claire) 
“And I think cos I feel like I handle it quite well I don’t want someone to panda to me, I 
don’t want to be pandered too.” (Claire) 
“Husband yes, yeh I would say, I mean of course he’s only ever known me with Crohn’s, 
erm so it’s just not an issue for him.” (Sally) 
“I had a very understanding flatmate who I would still consider to be my closest friend 
and I think she put up with a lot.” (Sally) 
Subordinate theme: Misunderstanding/dismissive others: 
“When I was really poorly my social life as well and people didn’t understand it, so that 
had quite a big impact on going out and seeing friends and then friends didn’t necessarily 
understand it so they’d get frustrated at you.” (Claire) 





“You can explain it as much as you, whereas it’s not always good enough for some 
people, because they don’t know what it’s like to be in your shoes.” (Claire) 
“It’s just like when you’re tired and people are like why you tired you know like just 
family say you shouldn’t be tired you’re young, it’s things like that and they don’t really 
know what they’re saying and they obviously they know what I’ve got but they just 
haven’t thought about what they’re saying to you.” (Claire) 
“I was only 15 so a lot of my friends wouldn’t have really understood.” (Harriet) 
“If I did have a flare up initially if I was at uni I’d feel a little like alone, so it kind of 
made me feel a bit more negative about the whole thing.” (Harriet) 
“Part of that independence, because like you’re very aware of what you need to do and 
how you can manage it, the people who don’t understand it are the barriers.” (Harriet) 
“Especially as when you’re younger you can get labels like a flake.” (Harriet) 
“It’s sometimes just easier not to tell people in the first place but then they’re not 
watching you and asking these questions.” (Harriet) 
 “I think that was out of anger and frustration more than anything else because nobody 
was listening or nobody really understood what I was going through and that really 
pissed me off.” (about developing an online support forum) (Sarah) 
“A lot of people find it difficult to understand anyway, it was a taboo subject.” (Sarah) 
 “Like it doesn’t make sense to them and people stop inviting you out to things because 
you don’t turn up very often because you’re not very well and its very painful and its 
exhausting to keep having to tell people that you’re still not well and you figure out who 
actually cares.” (Sarah) 





“They don’t understand and a lot of the time its upsets people when you’re not very 
well, like my mum if I actually tell her when I’m ill, how I feel and in what way she 
gets upset about that and I don’t think it’s worth upsetting her.” (Sarah) 
“I don’t have friends that are very dramatic and have a lot of issues that aren’t real 
issues because that stresses me out aswell.” (Sarah) 
 “We were sort of sat at the dinner table eating and I was just kind of I was just so upset 
about the whole thing and this daunting thing ahead of me and he just sort of said no no 
we’re not doing that don’t let your chin drop.” (Annie) 
“Partly because I had a very tough boss that would not have been allowed almost.” 
(Sally) 
“Those who have the condition, yes, those who don’t have the condition, not necessarily 
and there’s a sort of spectrum of how supportive they can be.” (Sally) 
“Because the excuses that other people might come up with, and you think really? actually 
that doesn’t register on the, erm, on the list of things that might disrupt your life.” (Sally) 
“I purposely avoided forums because they just, I think not to be mean but just some 
people wallow in being a victim of something.” (Annie) 
Subordinate theme: Stoicism/brave face 
“I don’t think I’ve ever taken time off for IBD.” (Sally) 
 “They try their very best but because I know they don’t really get were I’m coming 
from I tend to just brush it off and go with I’m fine.” (Sarah) 





“I don’t really tell a lot of people not a lot of people really know, only some of my close 
friends know some of them didn’t really get it so I don’t think there’s any need for people 
who aren’t that close to me to know, because it shouldn’t be impacting them.” (Claire) 
“There’s chairs and you can sit down but you want people to stand up because it’s better 
for people to think when they’re stood up and sometimes I’ve got to sit down when I 
should be the one who’s kind of, practicing what you preach and then you’re sat down 
and you’re like urgh I shouldn’t be doing this.” (Claire) 
“I suppose there’s that thing of sometimes when you are feeling pretty shit about it you 
don’t feel like there’s that many people to talk to about it and the ones you do speak to 
you feel like they’ve heard it all before and you don’t want to bog them down so you feel 
like you don’t want to sound like you’re being pathetic.” (Claire) 
“I can get into work every day and I manage to do these things so it’s kind of I shouldn’t 
really complain with how I am cos of what other people.” (Claire) 
“Probably times when I could of shouldn’t have been there, you know times like that 
when I force myself to do things.” (Claire) 
“I think people know there’s something, but they don’t know what it is.” (Claire) 
“You don’t have to look at me and ask me all these questions just like let that happen in 
the background, I do, just don’t worry about it.” (Harriet) 
“You just have to like push through it like still when I’m going through that I’m not gonna 
let anyone else in my life that doesn’t need to know that I’m going through that.” (Harriet) 
“Hate letting people down, but I wouldn’t want to take time off work because I’m yeh 
it’s not I don’t know I’d feel guilt as well.” (Harriet) 





“It’s sometimes just easier not to tell people in the first place but then they’re not watching 
you and asking these questions.” (Harriet)  







All online advertisements  
 
Crohn’s and Colitis UK advertisement: 
 




What the researchers will look at: 
The challenges of living with IBD can generate significant stress which can be 
difficult to cope with. As a result, many individuals experience periods of low mood, 
anxiety and low self-esteem. We are interested in identifying what helps individuals adapt 
to the challenges of living with IBD and reduce distress. Resilience is defined as the 
ability to “bounce back” from adversity and has been well researched in individuals with 
other physical health conditions. However, there is very little research and understanding 
about what factors enhance or hinder resilience in people living with IBD. Further 
knowledge could enable healthcare professionals to help those with IBD adapt and 
develop resilience in the face of IBD challenges. Factors that influence resilience could 
include the severity of the disease, the amount of social support one feels they have, how 
one copes with the condition or how in control one feels. 
Researchers at the University of Sheffield are looking for people aged 18 or over 
who have a confirmed diagnosis of IBD (this might include Crohn’s Disease, Ulcerative 





Colitis or Indeterminate IBD) to take part in a survey which aims to identify what factors 
help people feel resilient when living with IBD. 
The first part of this study has already been conducted. This was an interview 
study and identified traits, coping skills and experiences people with IBD thought may 
influence their own resilience. These findings have informed the development of the 
second part of the study; this online survey. The survey aims to identify what factors have 
the most influence on resilience across a wider population of individuals with IBD. 
Approximately 135 people are needed to complete this online survey so that the 
relationships between the identified factors and resilience can be statistically analysed. 
What do the researchers think this could mean for people with IBD?   
 
This research aims to understand what factors are most likely to enhance resilience 
in individuals with IBD. An improved understanding and evidence base means that 
psychological interventions (such as talking therapies) offered to individuals with IBD 
who are struggling with their mental and emotional health can be tailored to strengthen 
resilience in this population.  





Social media advertisement: 
 
"Do you have IBD? Looking for adults over 18 with IBD to participate in my online 
research study on resilience in people with IBD. To take part, please follow this 
link: https://sheffieldpsychology.eu.qualtrics.com/jfe/form/SV_af1OR152RMOMwLj”: 






University volunteer database: 
 
Email title:  




>I am researching resilience in people with IBD, as part of a study at the University of 
Sheffield. 
> 
>If you are over 18, have IBD and are interested please click on this link which will take you to 




>The research has been approved by the Research Ethics Committee in the Department of 
Psychology at the University of Sheffield. 
> 
>Thank you very much, 
> 
>Katie Boden 
>Trainee Clinical Psychologist 
> 














































Copy of all measures 
 











Connor-Davidson Resilience Scale (CD-RISC, Connor & Davidson, 2003). 
Removed for copyright reasons 
 
  








SPSS screenshots of tests of normality demonstrating Shapiro-Wilks tests. The 
Shapiro-Wilk test has more power to detect differences, therefore the significance level 
from this test was interpreted (Field, 2009). If the value of this was greater than 0.05 
(p>0.05), the data were deemed to be normally distributed. Therefore, disease activity, 
FSSQ data (social support), SGS (grit), CES (coping-efficacy), TSD and acceptance 
were deemed to be not normally distributed. The dependent variable of resilience was 
normally distributed.  



















SPSS output screenshots demonstrating kurtosis and skewess values, histograms and Q-
























































































Factors that associate with resilience in people with IBD 
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